data_1sx1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1sx1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.447 -0.633 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.508 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -37.12 -29.54 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -70.49 0.15 7.26 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 3' ' ' GLY . 6.0 t70 -108.43 144.88 30.4 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.59 0.233 . . . . 0.0 110.578 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.38 123.8 8.4 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.692 2.261 . . . . 0.0 112.314 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 t -38.66 134.67 0.98 Allowed Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.719 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.1 -21.41 65.53 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.576 2.184 . . . . 0.0 112.556 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -57.64 -30.25 65.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 0.0 111.031 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.34 34.69 11.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.522 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.7 p -90.15 -41.21 11.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.14 -28.72 2.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.459 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 153.16 20.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.707 0.289 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -74.99 163.53 27.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.56 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.0 -59.85 2.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.947 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.34 -24.67 3.14 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.049 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.449 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -98.11 -28.52 13.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.683 0.278 . . . . 0.0 111.718 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.0 t -107.19 -120.52 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.866 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.8 m80 . . . . . 0 N--CA 1.461 0.122 0 CA-C-O 120.703 0.287 . . . . 0.0 111.749 -179.169 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.497 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -34.72 -33.08 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.28 -7.82 4.86 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -99.06 144.79 28.86 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.634 0.254 . . . . 0.0 110.657 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.54 120.2 4.94 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.736 2.29 . . . . 0.0 112.306 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 t -34.57 133.72 0.41 Allowed Pre-proline 0 N--CA 1.467 0.385 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.742 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.73 -17.64 55.95 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.642 2.228 . . . . 0.0 112.72 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 p -57.18 -28.13 62.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.0 111.014 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.13 30.69 16.31 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.58 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.8 p -90.33 -49.16 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.828 0.347 . . . . 0.0 110.925 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.85 -27.13 2.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.422 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -88.27 150.56 23.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.807 0.336 . . . . 0.0 110.948 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -67.5 161.61 25.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.558 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.497 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -47.53 -66.29 0.43 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.302 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.83 -25.78 4.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.31 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -89.81 -19.67 24.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.358 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 t -119.05 -119.73 0.31 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.746 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.0 m80 . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.089 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.68 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.506 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -36.79 -29.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -69.49 -0.96 7.37 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.3 t70 -106.16 145.18 30.43 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.608 0.242 . . . . 0.0 110.633 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.2 122.58 6.61 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.862 2.375 . . . . 0.0 112.284 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 t -38.77 134.14 1.02 Allowed Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.653 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.14 -19.68 66.36 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.599 2.199 . . . . 0.0 112.752 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.0 p -55.68 -29.23 59.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.79 0.329 . . . . 0.0 111.057 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.52 32.0 9.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.611 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.8 p -90.07 -49.38 6.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.5 -27.91 2.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.466 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -89.97 154.09 20.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.56 161.93 29.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.592 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -46.49 -63.56 0.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.503 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.73 -25.68 4.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.582 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -89.99 -34.01 16.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.376 . . . . 0.0 111.156 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.9 t -104.54 -119.96 0.21 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.29 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.1 m80 . . . . . 0 N--CA 1.461 0.101 0 CA-C-O 120.745 0.307 . . . . 0.0 111.291 -179.603 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.504 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 34.4 ttt180 -47.12 -27.95 1.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -85.75 0.48 52.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -100.55 145.29 30.06 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.582 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -42.92 119.64 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.041 2.494 . . . . 0.0 112.441 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -38.04 135.11 0.85 Allowed Pre-proline 0 N--CA 1.465 0.291 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.668 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.7 -21.92 71.26 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.559 2.173 . . . . 0.0 112.648 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.7 p -57.45 -38.08 73.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.769 0.319 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.83 33.63 6.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.64 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.25 -29.72 17.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.77 -28.05 6.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.41 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 151.26 22.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.332 . . . . 0.0 110.77 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -71.15 166.5 21.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.538 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.504 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -48.7 -64.59 0.76 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.448 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -25.36 8.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.385 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -89.76 -26.83 20.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.272 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 15' ' ' LYS . 8.7 t -113.65 -120.05 0.3 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.263 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.4 m80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.731 0.301 . . . . 0.0 111.191 -179.557 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.494 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 4.1 ttt85 -47.41 -27.9 1.88 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -87.08 0.7 54.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.687 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.07 146.47 31.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.703 0.287 . . . . 0.0 110.591 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -42.61 119.08 1.31 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.749 2.299 . . . . 0.0 112.607 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 t -41.08 134.49 1.79 Allowed Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.546 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.01 -18.73 64.82 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.597 2.198 . . . . 0.0 112.799 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.3 p -55.94 -26.23 46.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.795 0.331 . . . . 0.0 111.17 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.07 28.71 22.38 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.675 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.4 p -90.33 -33.36 16.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.781 0.324 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.19 -28.41 6.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.38 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -83.81 152.68 24.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.332 . . . . 0.0 110.769 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.41 163.49 27.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.672 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.494 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -47.86 -61.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.159 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -54.37 -30.94 53.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.018 0.437 . . . . 0.0 110.891 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.47 8.3 34.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.419 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.08 -120.34 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.107 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.5 m80 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.73 0.3 . . . . 0.0 110.958 -179.779 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 12.6 ttp-105 -47.21 -27.73 1.6 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -85.06 0.65 50.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.67 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.1 146.46 31.75 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.698 0.285 . . . . 0.0 110.728 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -43.05 118.81 1.38 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.739 2.293 . . . . 0.0 112.655 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 t -40.26 134.44 1.49 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.516 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.22 -16.72 52.72 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.608 2.206 . . . . 0.0 112.777 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.6 p -56.76 -26.19 56.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 111.159 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.83 28.52 26.05 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.592 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.0 m -90.27 -40.51 12.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.05 -27.48 4.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.287 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -85.19 149.02 25.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.805 0.336 . . . . 0.0 110.771 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.51 165.95 17.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.768 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.486 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -49.79 -63.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.234 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.42 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 0.9 OUTLIER -52.17 -30.73 28.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.907 0.384 . . . . 0.0 110.985 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.03 8.69 31.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.571 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.2 -120.28 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.489 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.8 m80 . . . . . 0 C--O 1.233 0.203 0 O-C-N 122.328 -0.233 . . . . 0.0 111.575 -179.295 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.458 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 38.1 ttt180 -48.24 -27.89 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -86.11 0.35 53.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.7 0.286 . . . . 0.0 111.615 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -100.75 145.61 30.65 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.594 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -42.57 119.46 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.082 2.522 . . . . 0.0 112.416 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 t -38.67 135.25 0.96 Allowed Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.528 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.97 -20.91 38.78 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.569 2.179 . . . . 0.0 112.632 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -58.94 -28.35 66.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.772 0.32 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.05 34.08 24.88 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.636 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -90.14 -37.96 13.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.64 -27.85 3.47 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.478 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -89.33 140.29 29.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 0.0 110.917 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 165.52 3.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.723 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.37 -65.71 0.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.263 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -24.58 9.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.252 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -89.83 -18.34 26.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.263 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 t -121.96 -120.1 0.29 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.542 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.4 m80 . . . . . 0 C--O 1.231 0.131 0 O-C-N 122.25 -0.281 . . . . 0.0 111.713 -179.207 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.458 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -46.97 -28.88 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -84.73 0.83 49.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.649 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.18 145.25 30.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.635 0.255 . . . . 0.0 110.694 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.47 119.66 1.86 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.021 2.481 . . . . 0.0 112.444 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -38.67 134.78 0.98 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.619 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.22 -21.14 72.08 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.609 2.206 . . . . 0.0 112.555 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -56.61 -34.52 67.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.993 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.63 35.09 7.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.572 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -90.03 -51.39 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.0 110.914 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.75 -33.99 1.26 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.38 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -88.06 150.02 23.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.41 171.11 2.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.479 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.458 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -47.82 -70.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -24.09 19.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 111.014 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -93.39 13.27 22.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.307 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.2 t -150.14 -75.66 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.809 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.9 m80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 111.322 -179.522 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.506 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.7 ttt180 -47.0 -28.37 1.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -87.22 0.68 54.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -96.89 145.37 29.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.651 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -42.19 118.33 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.096 2.531 . . . . 0.0 112.503 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.432 ' H ' ' HA ' ' A' ' 15' ' ' LYS . 1.8 t -40.21 135.53 1.4 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.544 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.79 -21.82 37.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.52 2.147 . . . . 0.0 112.695 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.5 p -55.51 -29.09 58.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.763 0.316 . . . . 0.0 111.08 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.72 33.31 8.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.526 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -90.05 -32.15 16.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.361 . . . . 0.0 110.953 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.72 -31.75 4.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.487 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -87.85 166.3 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.328 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HA ' ' H ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -86.04 161.47 18.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.672 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -43.35 -63.14 0.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.784 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.46 -25.63 2.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.701 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.41 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -89.96 -43.42 10.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.958 0.408 . . . . 0.0 111.391 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.3 t -98.86 -112.56 0.16 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.723 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.7 m80 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.682 0.277 . . . . 0.0 111.566 -179.326 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.463 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.46 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.2 ttt180 -46.13 -28.72 1.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -84.95 0.39 51.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -101.69 145.74 31.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.678 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.15 119.94 2.28 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.99 2.46 . . . . 0.0 112.581 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -37.67 135.62 0.76 Allowed Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.694 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.35 -25.9 80.0 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.574 2.182 . . . . 0.0 112.449 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.4 p -57.84 -39.41 77.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.947 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.21 41.67 5.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.631 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.11 -42.29 11.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.38 -36.68 1.35 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.383 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 164.54 14.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.319 . . . . 0.0 110.739 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -178.07 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.536 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.46 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -57.78 -68.05 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.025 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -18.88 12.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.444 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -89.44 -29.6 18.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.6 t -107.04 -85.78 0.5 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.007 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.8 m80 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.72 0.295 . . . . 0.0 111.311 -179.285 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -34.99 -31.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -66.26 -3.54 6.02 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.9 t70 -102.14 144.81 29.33 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.655 0.264 . . . . 0.0 110.513 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -47.58 121.38 5.53 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.83 2.353 . . . . 0.0 112.302 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 t -36.52 134.31 0.61 Allowed Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.696 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.51 -20.22 69.24 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.561 2.174 . . . . 0.0 112.744 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.4 p -57.17 -33.86 67.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.834 0.35 . . . . 0.0 110.957 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.31 33.4 6.88 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.577 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 t -90.2 -44.03 10.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.04 -28.43 2.93 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.472 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -89.65 156.23 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.822 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -74.21 160.96 30.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.57 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.518 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -45.88 -60.21 2.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.64 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -51.83 -25.49 7.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.641 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.28 -35.6 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 0.0 111.247 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 t -102.31 -120.15 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.325 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.5 m80 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.762 0.315 . . . . 0.0 111.303 -179.548 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.641 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -36.64 -30.08 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -70.39 0.1 7.2 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.0 t70 -108.94 145.12 31.04 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-O 120.67 0.271 . . . . 0.0 110.701 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.3 Cg_endo -47.3 122.88 7.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.962 2.441 . . . . 0.0 112.705 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -38.41 135.71 0.89 Allowed Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.576 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.34 -24.11 75.61 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.55 2.167 . . . . 0.0 112.625 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.5 p -58.75 -30.06 67.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.77 38.66 8.59 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.546 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.4 m -90.01 -32.88 16.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.96 -40.1 1.67 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.56 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -85.25 166.11 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.767 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -74.58 -177.14 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.341 179.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.486 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -60.97 -58.41 8.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.942 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -63.14 -26.19 68.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.945 0.402 . . . . 0.0 110.791 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -92.71 15.01 15.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.25 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 t -150.02 -78.73 0.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.391 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.1 m80 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.643 179.838 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.697 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.507 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.52 -30.48 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.96 0.32 6.14 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -106.42 147.15 34.4 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.76 0.314 . . . . 0.0 110.736 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -48.6 122.71 8.32 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.657 2.238 . . . . 0.0 112.363 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.1 t -39.48 133.74 1.26 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.576 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 -16.25 54.35 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.541 2.161 . . . . 0.0 112.836 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.5 p -58.06 -29.2 65.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.757 0.313 . . . . 0.0 111.031 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.19 30.81 10.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.55 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 m -90.18 -50.61 5.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 0.0 110.967 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.39 -27.92 2.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -88.91 156.47 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.28 162.54 29.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.484 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.507 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.45 -62.28 1.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.3 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -25.12 9.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.401 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -90.84 -28.49 18.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 111.158 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.0 t -111.62 -120.07 0.29 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.207 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.5 m80 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.755 0.312 . . . . 0.0 111.375 -179.526 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.51 -30.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -72.26 0.66 9.32 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.5 t70 -107.16 145.31 30.9 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.681 0.277 . . . . 0.0 110.749 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -46.2 122.86 5.85 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.853 2.369 . . . . 0.0 112.554 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -40.02 135.5 1.35 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.656 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.92 -22.95 74.16 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.59 2.194 . . . . 0.0 112.581 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.7 p -59.1 -31.41 68.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 111.003 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.76 36.74 7.69 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.56 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -90.01 -31.41 17.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.985 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.51 -39.56 1.91 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.375 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.43 154.32 21.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 110.837 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.464 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -71.62 168.66 17.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.431 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -46.27 -61.83 1.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.004 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -29.34 62.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.667 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.464 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 7.8 mm100 -98.19 19.72 13.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.586 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.6 t -150.39 -80.54 0.12 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.577 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.7 m80 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.752 179.781 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.481 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.0 ttt180 -45.61 -28.94 1.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -86.38 0.39 54.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.603 0.239 . . . . 0.0 111.636 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.66 145.56 30.12 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.538 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.54 118.86 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.016 2.477 . . . . 0.0 112.585 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.9 t -38.88 135.32 1.0 Allowed Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.55 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.13 -20.39 67.64 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.574 2.183 . . . . 0.0 112.544 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.2 p -57.64 -29.18 64.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.349 . . . . 0.0 111.022 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.93 32.42 21.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.721 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -90.23 -29.77 17.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.927 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.46 -29.04 5.36 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.301 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -86.12 156.91 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.673 0.273 . . . . 0.0 110.791 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -178.51 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.407 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.481 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -64.74 -62.76 1.38 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.834 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -55.57 -28.29 54.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.956 0.408 . . . . 0.0 110.811 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.68 7.39 36.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.299 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 t -149.97 -120.03 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.965 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.6 m80 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.811 0.339 . . . . 0.0 110.91 -179.925 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.507 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -36.92 -29.94 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -178.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.99 0.24 9.87 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.7 t70 -106.88 145.21 30.64 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-O 120.712 0.291 . . . . 0.0 110.704 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.1 Cg_endo -46.52 122.26 5.57 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.9 2.4 . . . . 0.0 112.442 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -39.08 134.64 1.08 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.538 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.92 -19.47 64.0 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.612 2.208 . . . . 0.0 112.562 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -55.53 -29.87 59.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.018 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.02 33.28 9.04 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.556 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -89.8 -59.26 2.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.33 -28.61 0.78 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.607 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.05 155.55 17.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -68.07 166.46 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.522 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.507 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -45.86 -68.83 0.16 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.145 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -24.5 16.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -96.44 13.69 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.303 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 t -150.22 -74.85 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.836 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.7 m80 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.714 0.292 . . . . 0.0 111.316 -179.514 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.478 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 1.7 ttt85 -46.93 -28.05 1.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -86.9 0.87 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.717 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -99.42 145.54 30.24 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.574 0.226 . . . . 0.0 110.648 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -42.62 119.65 1.5 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.013 2.475 . . . . 0.0 112.451 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -39.2 135.24 1.09 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.57 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.94 -22.53 74.48 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.558 2.172 . . . . 0.0 112.591 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -56.61 -30.58 63.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.36 36.12 10.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.576 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -90.02 -48.42 7.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.911 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.31 -28.23 1.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.406 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -92.83 152.25 19.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -72.8 163.13 28.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.668 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.478 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -45.97 -60.93 1.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.661 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -49.43 -26.54 3.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.936 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.414 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 10.7 mm-40 -92.91 -43.29 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.546 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.2 t -91.88 -120.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.723 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.1 m80 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.713 0.292 . . . . 0.0 111.505 -179.338 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.523 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -35.71 -30.52 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -70.49 0.14 7.3 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.4 t70 -104.71 145.34 30.51 Favored Pre-proline 0 C--O 1.232 0.16 0 CA-C-O 120.629 0.252 . . . . 0.0 110.632 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -46.94 121.54 5.18 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.903 2.402 . . . . 0.0 112.35 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -37.75 135.19 0.79 Allowed Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.603 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.23 -23.49 59.61 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.519 2.146 . . . . 0.0 112.658 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.5 p -57.01 -29.72 63.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.93 37.46 6.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.523 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.8 p -90.14 -34.62 15.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.03 -26.14 5.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.459 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -96.53 160.73 14.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 0.0 110.923 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -73.32 166.12 23.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.521 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.523 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -49.09 -68.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.352 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.24 -24.63 2.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.632 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -89.76 -27.34 20.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.63 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 15' ' ' LYS . 12.0 t -110.04 -80.98 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.0 m80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.491 -179.34 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.568 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.481 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 1.1 ttt85 -46.4 -28.6 1.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -87.0 1.1 53.94 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -97.77 145.32 29.54 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.701 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -42.58 118.83 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.067 2.511 . . . . 0.0 112.487 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -40.29 135.19 1.45 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.66 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.4 -21.5 66.5 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.533 2.156 . . . . 0.0 112.549 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.6 p -56.37 -30.36 62.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.337 . . . . 0.0 111.009 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.12 33.97 10.24 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.517 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -90.07 -35.55 15.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.814 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.38 -28.33 4.29 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.451 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -89.11 163.42 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -85.74 160.15 19.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 179.717 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.481 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -43.65 -62.16 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.751 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -47.97 -27.37 2.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.003 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.429 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 2.5 tt0 -94.6 -36.76 11.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.65 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 t -99.85 -120.13 0.15 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.538 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.0 m80 . . . . . 0 C--O 1.231 0.108 0 O-C-N 122.274 -0.266 . . . . 0.0 111.654 -179.296 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.447 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.462 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 14.2 ttp180 -47.83 -28.04 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -84.22 0.78 47.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.616 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -101.5 145.19 30.02 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.64 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -42.42 120.0 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.092 2.528 . . . . 0.0 112.39 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -40.21 135.67 1.39 Allowed Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.478 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.66 -20.26 49.77 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.546 2.164 . . . . 0.0 112.604 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.0 p -60.04 -31.33 69.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.87 0.367 . . . . 0.0 110.893 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.57 35.53 13.71 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.57 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -90.18 -44.92 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.909 0.385 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.74 -29.14 2.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.434 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.73 134.17 34.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -55.8 166.18 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.759 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.462 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -45.9 -61.06 1.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.584 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.41 -35.41 51.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.534 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.421 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 9.1 mm100 -90.61 13.73 15.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.573 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 t -150.36 -120.6 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.545 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.3 m80 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.69 0.281 . . . . 0.0 111.44 -179.612 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.856 0.36 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.8 p -123.45 158.87 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.195 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -81.24 84.65 1.43 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.436 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.508 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -37.12 -29.54 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -70.49 0.15 7.26 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 3' ' ' GLY . 6.0 t70 -108.43 144.88 30.4 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.59 0.233 . . . . 0.0 110.578 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.38 123.8 8.4 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.692 2.261 . . . . 0.0 112.314 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 t -38.66 134.67 0.98 Allowed Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.719 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.1 -21.41 65.53 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.576 2.184 . . . . 0.0 112.556 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -57.64 -30.25 65.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 0.0 111.031 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.34 34.69 11.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.522 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.7 p -90.15 -41.21 11.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.14 -28.72 2.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.459 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 153.16 20.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.707 0.289 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -74.99 163.53 27.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.56 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.0 -59.85 2.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.947 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.34 -24.67 3.14 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.049 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.449 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -98.11 -28.52 13.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.683 0.278 . . . . 0.0 111.718 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.0 t -107.19 -120.52 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.866 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -60.8 -38.52 85.65 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.703 0.287 . . . . 0.0 111.749 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.77 -27.52 4.75 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.837 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.858 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.781 0.324 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.446 ' CG1' ' CD2' ' A' ' 16' ' ' TYR . 12.9 p -114.74 149.27 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.297 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.19 81.16 0.58 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.283 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.497 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -34.72 -33.08 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.28 -7.82 4.86 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -99.06 144.79 28.86 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.634 0.254 . . . . 0.0 110.657 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.54 120.2 4.94 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.736 2.29 . . . . 0.0 112.306 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 t -34.57 133.72 0.41 Allowed Pre-proline 0 N--CA 1.467 0.385 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.742 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.73 -17.64 55.95 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.642 2.228 . . . . 0.0 112.72 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 p -57.18 -28.13 62.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.0 111.014 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.13 30.69 16.31 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.58 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.8 p -90.33 -49.16 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.828 0.347 . . . . 0.0 110.925 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.85 -27.13 2.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.422 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -88.27 150.56 23.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.807 0.336 . . . . 0.0 110.948 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -67.5 161.61 25.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.558 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.497 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -47.53 -66.29 0.43 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.302 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.83 -25.78 4.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.31 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -89.81 -19.67 24.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.358 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 t -119.05 -119.73 0.31 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.746 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -67.31 -22.54 65.62 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.3 -27.22 5.39 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.835 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.871 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.46 ' CG1' ' CD2' ' A' ' 16' ' ' TYR . 14.1 p -120.03 158.53 21.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -76.76 81.99 1.1 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.412 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.506 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -36.79 -29.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -69.49 -0.96 7.37 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.3 t70 -106.16 145.18 30.43 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.608 0.242 . . . . 0.0 110.633 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.2 122.58 6.61 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.862 2.375 . . . . 0.0 112.284 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 t -38.77 134.14 1.02 Allowed Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.653 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.14 -19.68 66.36 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.599 2.199 . . . . 0.0 112.752 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.0 p -55.68 -29.23 59.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.79 0.329 . . . . 0.0 111.057 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.52 32.0 9.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.611 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.8 p -90.07 -49.38 6.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.5 -27.91 2.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.466 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -89.97 154.09 20.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.56 161.93 29.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.592 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -46.49 -63.56 0.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.503 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.73 -25.68 4.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.582 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -89.99 -34.01 16.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.376 . . . . 0.0 111.156 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.9 t -104.54 -119.96 0.21 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.29 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -53.18 -46.07 68.81 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.745 0.307 . . . . 0.0 111.291 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.35 -44.79 65.92 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.54 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.884 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.802 0.334 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.478 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.2 p -102.96 147.47 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.49 95.07 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.481 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.504 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 34.4 ttt180 -47.12 -27.95 1.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -85.75 0.48 52.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -100.55 145.29 30.06 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.582 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -42.92 119.64 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.041 2.494 . . . . 0.0 112.441 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -38.04 135.11 0.85 Allowed Pre-proline 0 N--CA 1.465 0.291 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.668 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.7 -21.92 71.26 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.559 2.173 . . . . 0.0 112.648 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.7 p -57.45 -38.08 73.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.769 0.319 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.83 33.63 6.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.64 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.25 -29.72 17.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.77 -28.05 6.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.41 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 151.26 22.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.332 . . . . 0.0 110.77 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -71.15 166.5 21.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.538 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.504 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -48.7 -64.59 0.76 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.448 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -25.36 8.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.385 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -89.76 -26.83 20.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.272 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 15' ' ' LYS . 8.7 t -113.65 -120.05 0.3 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.263 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -59.13 -43.51 91.97 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.731 0.301 . . . . 0.0 111.191 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.41 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -54.02 -23.43 23.87 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.684 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.959 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.855 0.359 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.479 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.9 p -114.86 146.79 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.18 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.79 96.56 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.327 -0.94 . . . . 0.0 111.275 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.494 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 4.1 ttt85 -47.41 -27.9 1.88 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -87.08 0.7 54.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.687 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.07 146.47 31.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.703 0.287 . . . . 0.0 110.591 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -42.61 119.08 1.31 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.749 2.299 . . . . 0.0 112.607 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 t -41.08 134.49 1.79 Allowed Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.546 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.01 -18.73 64.82 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.597 2.198 . . . . 0.0 112.799 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.3 p -55.94 -26.23 46.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.795 0.331 . . . . 0.0 111.17 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.07 28.71 22.38 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.675 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.4 p -90.33 -33.36 16.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.781 0.324 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.19 -28.41 6.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.38 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -83.81 152.68 24.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.332 . . . . 0.0 110.769 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.41 163.49 27.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.672 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.494 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -47.86 -61.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.159 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -54.37 -30.94 53.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.018 0.437 . . . . 0.0 110.891 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.47 8.3 34.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.419 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.08 -120.34 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.107 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -59.17 -40.59 86.11 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.73 0.3 . . . . 0.0 110.958 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.09 -40.74 93.99 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.378 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.328 -0.844 . . . . 0.0 110.959 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.726 0.298 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.475 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.8 p -123.92 147.21 28.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.187 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.24 94.74 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.244 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 12.6 ttp-105 -47.21 -27.73 1.6 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -85.06 0.65 50.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.67 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.1 146.46 31.75 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.698 0.285 . . . . 0.0 110.728 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -43.05 118.81 1.38 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.739 2.293 . . . . 0.0 112.655 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 t -40.26 134.44 1.49 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.516 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.22 -16.72 52.72 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.608 2.206 . . . . 0.0 112.777 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.6 p -56.76 -26.19 56.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 111.159 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.83 28.52 26.05 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.592 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.0 m -90.27 -40.51 12.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.05 -27.48 4.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.287 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -85.19 149.02 25.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.805 0.336 . . . . 0.0 110.771 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.51 165.95 17.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.768 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.486 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -49.79 -63.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.234 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.42 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 0.9 OUTLIER -52.17 -30.73 28.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.907 0.384 . . . . 0.0 110.985 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.03 8.69 31.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.571 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.2 -120.28 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.489 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -66.37 -27.08 67.6 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 122.328 -0.233 . . . . 0.0 111.575 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.28 -26.22 9.16 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.787 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.886 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.3 mmtm . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.85 0.357 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 12.7 p -93.54 144.35 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.3 97.22 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.363 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.458 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 38.1 ttt180 -48.24 -27.89 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -86.11 0.35 53.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.7 0.286 . . . . 0.0 111.615 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -100.75 145.61 30.65 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.594 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -42.57 119.46 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.082 2.522 . . . . 0.0 112.416 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 t -38.67 135.25 0.96 Allowed Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.528 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.97 -20.91 38.78 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.569 2.179 . . . . 0.0 112.632 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -58.94 -28.35 66.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.772 0.32 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.05 34.08 24.88 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.636 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -90.14 -37.96 13.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.64 -27.85 3.47 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.478 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -89.33 140.29 29.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 0.0 110.917 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 165.52 3.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.723 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.467 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -48.37 -65.71 0.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.263 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -24.58 9.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.252 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -89.83 -18.34 26.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.263 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 t -121.96 -120.1 0.29 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.542 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -66.73 -30.32 70.52 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 122.25 -0.281 . . . . 0.0 111.713 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.426 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -49.37 -26.45 6.94 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.793 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.912 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.765 0.316 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.492 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 9.7 p -117.11 150.26 19.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.15 94.82 0.1 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.318 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.458 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -46.97 -28.88 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -84.73 0.83 49.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.649 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.18 145.25 30.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.635 0.255 . . . . 0.0 110.694 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.47 119.66 1.86 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.021 2.481 . . . . 0.0 112.444 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -38.67 134.78 0.98 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.619 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.22 -21.14 72.08 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.609 2.206 . . . . 0.0 112.555 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -56.61 -34.52 67.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.993 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.63 35.09 7.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.572 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -90.03 -51.39 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.0 110.914 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.75 -33.99 1.26 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.38 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -88.06 150.02 23.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.41 171.11 2.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.479 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.492 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -47.82 -70.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -24.09 19.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 111.014 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -93.39 13.27 22.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.307 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.2 t -150.14 -75.66 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.809 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -114.18 -35.21 5.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 111.322 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.8 -25.12 14.84 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.666 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.798 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.2 mttm . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.855 0.36 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.494 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 12.8 p -111.89 144.18 20.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.172 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.15 96.37 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.391 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.506 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.7 ttt180 -47.0 -28.37 1.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -87.22 0.68 54.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -96.89 145.37 29.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.651 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -42.19 118.33 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.096 2.531 . . . . 0.0 112.503 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.432 ' H ' ' HA ' ' A' ' 15' ' ' LYS . 1.8 t -40.21 135.53 1.4 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.544 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.79 -21.82 37.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.52 2.147 . . . . 0.0 112.695 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.5 p -55.51 -29.09 58.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.763 0.316 . . . . 0.0 111.08 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.72 33.31 8.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.526 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -90.05 -32.15 16.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.361 . . . . 0.0 110.953 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.72 -31.75 4.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.487 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -87.85 166.3 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.328 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HA ' ' H ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -86.04 161.47 18.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.672 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -43.35 -63.14 0.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.784 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.46 -25.63 2.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.701 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.41 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -89.96 -43.42 10.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.958 0.408 . . . . 0.0 111.391 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.3 t -98.86 -112.56 0.16 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.723 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -55.11 -53.45 55.72 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.682 0.277 . . . . 0.0 111.566 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.02 -28.09 3.84 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.941 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.3 mptt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.807 0.337 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.506 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.3 p -110.9 143.77 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.222 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.41 96.74 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.289 -0.957 . . . . 0.0 111.322 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.46 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.2 ttt180 -46.13 -28.72 1.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -84.95 0.39 51.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -101.69 145.74 31.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.678 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.15 119.94 2.28 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.99 2.46 . . . . 0.0 112.581 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -37.67 135.62 0.76 Allowed Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.694 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.35 -25.9 80.0 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.574 2.182 . . . . 0.0 112.449 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.4 p -57.84 -39.41 77.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.947 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.21 41.67 5.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.631 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.11 -42.29 11.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.38 -36.68 1.35 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.383 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 164.54 14.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.319 . . . . 0.0 110.739 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -178.07 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.536 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.506 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.4 OUTLIER -57.78 -68.05 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.025 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -18.88 12.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.444 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -89.44 -29.6 18.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.6 t -107.04 -85.78 0.5 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.007 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -87.7 -51.47 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.72 0.295 . . . . 0.0 111.311 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . -47.2 -30.91 5.86 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.73 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.005 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.825 0.345 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.455 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.5 p -107.58 149.94 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.256 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -71.53 80.81 0.52 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.269 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -34.99 -31.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -66.26 -3.54 6.02 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.9 t70 -102.14 144.81 29.33 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.655 0.264 . . . . 0.0 110.513 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -47.58 121.38 5.53 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.83 2.353 . . . . 0.0 112.302 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 t -36.52 134.31 0.61 Allowed Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.696 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.51 -20.22 69.24 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.561 2.174 . . . . 0.0 112.744 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.4 p -57.17 -33.86 67.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.834 0.35 . . . . 0.0 110.957 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.31 33.4 6.88 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.577 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 t -90.2 -44.03 10.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.04 -28.43 2.93 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.472 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -89.65 156.23 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.822 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -74.21 160.96 30.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.57 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.518 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -45.88 -60.21 2.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.64 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -51.83 -25.49 7.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.641 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.28 -35.6 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 0.0 111.247 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 t -102.31 -120.15 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.325 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -56.72 -47.77 79.22 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.762 0.315 . . . . 0.0 111.303 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.427 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -52.54 -24.47 17.7 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.743 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.868 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.85 0.357 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.475 ' CG1' ' CD2' ' A' ' 16' ' ' TYR . 14.0 p -119.01 158.92 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -82.7 85.97 1.48 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.398 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -36.64 -30.08 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -70.39 0.1 7.2 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.0 t70 -108.94 145.12 31.04 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-O 120.67 0.271 . . . . 0.0 110.701 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.3 Cg_endo -47.3 122.88 7.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.962 2.441 . . . . 0.0 112.705 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -38.41 135.71 0.89 Allowed Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.576 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.34 -24.11 75.61 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.55 2.167 . . . . 0.0 112.625 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.5 p -58.75 -30.06 67.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.77 38.66 8.59 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.546 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.4 m -90.01 -32.88 16.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.96 -40.1 1.67 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.56 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -85.25 166.11 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.767 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -74.58 -177.14 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.341 179.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.486 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -60.97 -58.41 8.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.942 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -63.14 -26.19 68.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.945 0.402 . . . . 0.0 110.791 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -92.71 15.01 15.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.25 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 t -150.02 -78.73 0.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.391 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 22' ' ' ARG . 28.1 m80 -105.64 -86.14 0.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.643 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.445 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . 52.22 -84.06 0.01 OUTLIER Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.927 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 20' ' ' HIS . 4.2 mtt180 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.79 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.762 0.315 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.455 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.7 p -102.81 158.28 4.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -78.81 84.36 1.22 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.337 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.507 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.52 -30.48 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.96 0.32 6.14 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -106.42 147.15 34.4 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.76 0.314 . . . . 0.0 110.736 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -48.6 122.71 8.32 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.657 2.238 . . . . 0.0 112.363 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.1 t -39.48 133.74 1.26 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.576 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 -16.25 54.35 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.541 2.161 . . . . 0.0 112.836 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.5 p -58.06 -29.2 65.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.757 0.313 . . . . 0.0 111.031 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.19 30.81 10.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.55 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 m -90.18 -50.61 5.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 0.0 110.967 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.39 -27.92 2.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -88.91 156.47 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.28 162.54 29.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.484 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.507 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.45 -62.28 1.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.3 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -25.12 9.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.401 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -90.84 -28.49 18.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 111.158 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.0 t -111.62 -120.07 0.29 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.207 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -58.09 -45.0 87.91 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.755 0.312 . . . . 0.0 111.375 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.424 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -51.89 -25.04 15.31 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.765 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.939 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.6 mttt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.726 0.298 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.483 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.9 p -118.14 158.76 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.251 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -80.15 84.1 1.36 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.249 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.51 -30.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -72.26 0.66 9.32 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.5 t70 -107.16 145.31 30.9 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.681 0.277 . . . . 0.0 110.749 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -46.2 122.86 5.85 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.853 2.369 . . . . 0.0 112.554 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -40.02 135.5 1.35 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.656 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.92 -22.95 74.16 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.59 2.194 . . . . 0.0 112.581 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.7 p -59.1 -31.41 68.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 111.003 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.76 36.74 7.69 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.56 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -90.01 -31.41 17.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.985 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.51 -39.56 1.91 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.375 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.43 154.32 21.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 110.837 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.464 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -71.62 168.66 17.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.431 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -46.27 -61.83 1.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.004 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -29.34 62.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.667 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.464 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 7.8 mm100 -98.19 19.72 13.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.586 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.6 t -150.39 -80.54 0.12 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.577 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.484 ' O ' ' N ' ' A' ' 22' ' ' ARG . 24.7 m80 -105.72 -88.34 0.44 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.752 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . 52.81 -83.77 0.01 OUTLIER Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.825 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 20' ' ' HIS . 6.3 mtt-85 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.912 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.3 mttt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.795 0.331 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.494 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 11.8 p -88.3 145.79 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.19 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.51 96.71 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.073 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.481 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.0 ttt180 -45.61 -28.94 1.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -86.38 0.39 54.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.603 0.239 . . . . 0.0 111.636 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.66 145.56 30.12 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.538 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.54 118.86 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.016 2.477 . . . . 0.0 112.585 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.9 t -38.88 135.32 1.0 Allowed Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.55 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.13 -20.39 67.64 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.574 2.183 . . . . 0.0 112.544 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.2 p -57.64 -29.18 64.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.349 . . . . 0.0 111.022 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.93 32.42 21.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.721 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -90.23 -29.77 17.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.927 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.46 -29.04 5.36 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.301 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -86.12 156.91 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.673 0.273 . . . . 0.0 110.791 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -178.51 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.407 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.494 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -64.74 -62.76 1.38 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.834 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -55.57 -28.29 54.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.956 0.408 . . . . 0.0 110.811 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.68 7.39 36.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.299 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 t -149.97 -120.03 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.965 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -59.76 -40.2 87.36 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.811 0.339 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.17 -40.19 95.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.534 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.905 0.383 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.474 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.7 p -109.7 158.63 9.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.214 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -81.29 84.46 1.44 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.256 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.507 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -36.92 -29.94 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -178.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.99 0.24 9.87 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.7 t70 -106.88 145.21 30.64 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-O 120.712 0.291 . . . . 0.0 110.704 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.1 Cg_endo -46.52 122.26 5.57 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.9 2.4 . . . . 0.0 112.442 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -39.08 134.64 1.08 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.538 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.92 -19.47 64.0 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.612 2.208 . . . . 0.0 112.562 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -55.53 -29.87 59.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.018 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.02 33.28 9.04 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.556 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -89.8 -59.26 2.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.33 -28.61 0.78 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.607 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.05 155.55 17.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -68.07 166.46 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.522 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.507 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -45.86 -68.83 0.16 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.145 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -24.5 16.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -96.44 13.69 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.303 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 t -150.22 -74.85 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.836 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -117.84 -36.1 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.714 0.292 . . . . 0.0 111.316 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.454 ' CA ' ' CD2' ' A' ' 16' ' ' TYR . . . -47.68 -27.93 4.85 Favored Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.844 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.817 0.341 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.487 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 11.6 p -101.04 149.41 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.27 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.08 93.82 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.263 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.478 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 1.7 ttt85 -46.93 -28.05 1.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -86.9 0.87 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.717 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -99.42 145.54 30.24 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.574 0.226 . . . . 0.0 110.648 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -42.62 119.65 1.5 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.013 2.475 . . . . 0.0 112.451 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -39.2 135.24 1.09 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.57 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.94 -22.53 74.48 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.558 2.172 . . . . 0.0 112.591 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -56.61 -30.58 63.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.36 36.12 10.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.576 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -90.02 -48.42 7.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.911 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.31 -28.23 1.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.406 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -92.83 152.25 19.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -72.8 163.13 28.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.668 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.487 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -45.97 -60.93 1.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.661 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -49.43 -26.54 3.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.936 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.414 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 10.7 mm-40 -92.91 -43.29 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.546 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.2 t -91.88 -120.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.723 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -59.63 -45.6 91.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.713 0.292 . . . . 0.0 111.505 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.421 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -50.98 -25.45 9.82 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.844 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.862 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.9 mtmm . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.791 0.329 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.4 p -117.66 152.56 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.204 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -72.78 80.78 0.66 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.253 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.523 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -35.71 -30.52 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -70.49 0.14 7.3 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.4 t70 -104.71 145.34 30.51 Favored Pre-proline 0 C--O 1.232 0.16 0 CA-C-O 120.629 0.252 . . . . 0.0 110.632 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -46.94 121.54 5.18 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.903 2.402 . . . . 0.0 112.35 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -37.75 135.19 0.79 Allowed Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.603 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.23 -23.49 59.61 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.519 2.146 . . . . 0.0 112.658 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.5 p -57.01 -29.72 63.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.93 37.46 6.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.523 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.8 p -90.14 -34.62 15.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.03 -26.14 5.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.459 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -96.53 160.73 14.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 0.0 110.923 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -73.32 166.12 23.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.521 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.523 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -49.09 -68.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.352 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HA ' ' N ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -50.24 -24.63 2.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.632 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -89.76 -27.34 20.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.63 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 15' ' ' LYS . 12.0 t -110.04 -80.98 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -100.28 -47.39 4.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.491 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.05 -28.05 3.87 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.758 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.406 ' N ' ' HA ' ' A' ' 17' ' ' LYS . 6.9 mmt180 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.801 0.334 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.502 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.9 p -84.28 144.99 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.67 96.45 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.279 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.481 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 1.1 ttt85 -46.4 -28.6 1.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -87.0 1.1 53.94 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -97.77 145.32 29.54 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.701 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -42.58 118.83 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.067 2.511 . . . . 0.0 112.487 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -40.29 135.19 1.45 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.66 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.4 -21.5 66.5 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.533 2.156 . . . . 0.0 112.549 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.6 p -56.37 -30.36 62.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.337 . . . . 0.0 111.009 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.12 33.97 10.24 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.517 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -90.07 -35.55 15.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.814 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.38 -28.33 4.29 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.451 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -89.11 163.42 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -85.74 160.15 19.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 179.717 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.502 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -43.65 -62.16 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.751 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -47.97 -27.37 2.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.003 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.429 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 2.5 tt0 -94.6 -36.76 11.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.65 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 t -99.85 -120.13 0.15 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.538 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -57.76 -47.3 82.88 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 122.274 -0.266 . . . . 0.0 111.654 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.406 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -47.1 -45.26 20.25 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.92 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.965 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.916 0.388 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.498 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 12.1 p -102.87 138.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.128 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.29 98.22 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.496 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.462 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 14.2 ttp180 -47.83 -28.04 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -84.22 0.78 47.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.616 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -101.5 145.19 30.02 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.64 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -42.42 120.0 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.092 2.528 . . . . 0.0 112.39 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -40.21 135.67 1.39 Allowed Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.478 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.66 -20.26 49.77 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.546 2.164 . . . . 0.0 112.604 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.0 p -60.04 -31.33 69.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.87 0.367 . . . . 0.0 110.893 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.57 35.53 13.71 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.57 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -90.18 -44.92 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.909 0.385 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.74 -29.14 2.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.434 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.73 134.17 34.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -55.8 166.18 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.759 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.498 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -45.9 -61.06 1.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.584 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.41 -35.41 51.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.534 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.421 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 9.1 mm100 -90.61 13.73 15.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.573 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 t -150.36 -120.6 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.545 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -67.4 -28.27 67.78 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.69 0.281 . . . . 0.0 111.44 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.08 -24.44 20.85 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.76 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.447 -0.633 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.512 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -37.12 -29.54 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -70.49 0.15 7.26 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 3' ' ' GLY . 6.0 t70 -108.43 144.88 30.4 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.59 0.233 . . . . 0.0 110.578 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.3 Cg_endo -47.38 123.8 8.4 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.692 2.261 . . . . 0.0 112.314 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 t -38.66 134.67 0.98 Allowed Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.719 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.1 -21.41 65.53 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.576 2.184 . . . . 0.0 112.556 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -57.64 -30.25 65.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 0.0 111.031 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.34 34.69 11.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.522 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.7 p -90.15 -41.21 11.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.14 -28.72 2.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.459 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 153.16 20.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.707 0.289 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -74.99 163.53 27.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.56 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.512 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.0 -59.85 2.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.947 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.402 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -50.34 -24.67 3.14 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.049 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.476 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -98.11 -28.52 13.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.683 0.278 . . . . 0.0 111.718 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.0 t -107.19 -120.52 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.866 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.8 m80 . . . . . 0 N--CA 1.461 0.122 0 CA-C-O 120.703 0.287 . . . . 0.0 111.749 -179.169 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.498 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -34.72 -33.08 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.28 -7.82 4.86 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -99.06 144.79 28.86 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.634 0.254 . . . . 0.0 110.657 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.4 Cg_endo -48.54 120.2 4.94 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.736 2.29 . . . . 0.0 112.306 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 t -34.57 133.72 0.41 Allowed Pre-proline 0 N--CA 1.467 0.385 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.742 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.73 -17.64 55.95 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.642 2.228 . . . . 0.0 112.72 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 p -57.18 -28.13 62.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.0 111.014 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.13 30.69 16.31 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.58 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.8 p -90.33 -49.16 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.828 0.347 . . . . 0.0 110.925 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.85 -27.13 2.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.422 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -88.27 150.56 23.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.807 0.336 . . . . 0.0 110.948 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -67.5 161.61 25.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.558 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.498 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -47.53 -66.29 0.43 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.302 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.83 -25.78 4.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.31 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -89.81 -19.67 24.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.358 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 t -119.05 -119.73 0.31 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.746 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.0 m80 . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.089 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.68 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.509 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -36.79 -29.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.409 ' O ' ' ND2' ' A' ' 5' ' ' ASN . 0.2 OUTLIER -69.49 -0.96 7.37 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.3 t70 -106.16 145.18 30.43 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.608 0.242 . . . . 0.0 110.633 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.3 Cg_endo -47.2 122.58 6.61 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.862 2.375 . . . . 0.0 112.284 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 t -38.77 134.14 1.02 Allowed Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.653 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.14 -19.68 66.36 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.599 2.199 . . . . 0.0 112.752 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.0 p -55.68 -29.23 59.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.79 0.329 . . . . 0.0 111.057 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.52 32.0 9.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.611 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.8 p -90.07 -49.38 6.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.5 -27.91 2.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.466 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -89.97 154.09 20.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -70.56 161.93 29.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.592 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.509 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -46.49 -63.56 0.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.503 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.73 -25.68 4.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.582 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -89.99 -34.01 16.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.376 . . . . 0.0 111.156 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.9 t -104.54 -119.96 0.21 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.29 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.1 m80 . . . . . 0 N--CA 1.461 0.101 0 CA-C-O 120.745 0.307 . . . . 0.0 111.291 -179.603 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.521 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 34.4 ttt180 -47.12 -27.95 1.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -85.75 0.48 52.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -100.55 145.29 30.06 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.582 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.2 Cg_endo -42.92 119.64 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.041 2.494 . . . . 0.0 112.441 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -38.04 135.11 0.85 Allowed Pre-proline 0 N--CA 1.465 0.291 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.668 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.7 -21.92 71.26 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.559 2.173 . . . . 0.0 112.648 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.7 p -57.45 -38.08 73.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.769 0.319 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.83 33.63 6.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.64 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.25 -29.72 17.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.77 -28.05 6.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.41 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 151.26 22.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.332 . . . . 0.0 110.77 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -71.15 166.5 21.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.538 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.521 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -48.7 -64.59 0.76 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.448 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -25.36 8.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.385 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -89.76 -26.83 20.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.272 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 15' ' ' LYS . 8.7 t -113.65 -120.05 0.3 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.263 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.4 m80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.731 0.301 . . . . 0.0 111.191 -179.557 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.508 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 4.1 ttt85 -47.41 -27.9 1.88 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -87.08 0.7 54.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.687 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.07 146.47 31.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.703 0.287 . . . . 0.0 110.591 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 98.7 Cg_exo -42.61 119.08 1.31 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.749 2.299 . . . . 0.0 112.607 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 t -41.08 134.49 1.79 Allowed Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.546 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.01 -18.73 64.82 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.597 2.198 . . . . 0.0 112.799 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.3 p -55.94 -26.23 46.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.795 0.331 . . . . 0.0 111.17 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.07 28.71 22.38 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.675 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.4 p -90.33 -33.36 16.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.781 0.324 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.19 -28.41 6.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.38 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -83.81 152.68 24.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.332 . . . . 0.0 110.769 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -72.41 163.49 27.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.672 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -47.86 -61.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.159 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -54.37 -30.94 53.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.018 0.437 . . . . 0.0 110.891 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.47 8.3 34.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.419 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.08 -120.34 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.107 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.5 m80 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.73 0.3 . . . . 0.0 110.958 -179.779 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.502 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 12.6 ttp-105 -47.21 -27.73 1.6 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -85.06 0.65 50.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.67 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.1 146.46 31.75 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.698 0.285 . . . . 0.0 110.728 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 96.3 Cg_exo -43.05 118.81 1.38 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.739 2.293 . . . . 0.0 112.655 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 t -40.26 134.44 1.49 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.516 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.22 -16.72 52.72 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.608 2.206 . . . . 0.0 112.777 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.6 p -56.76 -26.19 56.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 111.159 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.83 28.52 26.05 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.592 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.0 m -90.27 -40.51 12.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.05 -27.48 4.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.287 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -85.19 149.02 25.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.805 0.336 . . . . 0.0 110.771 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -68.51 165.95 17.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.768 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.502 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -49.79 -63.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.234 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 0.9 OUTLIER -52.17 -30.73 28.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.907 0.384 . . . . 0.0 110.985 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.03 8.69 31.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.571 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.2 -120.28 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.489 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.8 m80 . . . . . 0 C--O 1.233 0.203 0 O-C-N 122.328 -0.233 . . . . 0.0 111.575 -179.295 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.475 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 38.1 ttt180 -48.24 -27.89 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -86.11 0.35 53.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.7 0.286 . . . . 0.0 111.615 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -100.75 145.61 30.65 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.594 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.2 Cg_endo -42.57 119.46 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.082 2.522 . . . . 0.0 112.416 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 t -38.67 135.25 0.96 Allowed Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.528 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.97 -20.91 38.78 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.569 2.179 . . . . 0.0 112.632 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -58.94 -28.35 66.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.772 0.32 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.05 34.08 24.88 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.636 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -90.14 -37.96 13.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.64 -27.85 3.47 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.478 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -89.33 140.29 29.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 0.0 110.917 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.26 165.52 3.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.723 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.475 ' HB3' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.37 -65.71 0.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.263 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -24.58 9.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.252 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -89.83 -18.34 26.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.263 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 t -121.96 -120.1 0.29 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.542 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.4 m80 . . . . . 0 C--O 1.231 0.131 0 O-C-N 122.25 -0.281 . . . . 0.0 111.713 -179.207 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.474 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -46.97 -28.88 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -84.73 0.83 49.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.649 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.18 145.25 30.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.635 0.255 . . . . 0.0 110.694 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -43.47 119.66 1.86 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.021 2.481 . . . . 0.0 112.444 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -38.67 134.78 0.98 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.619 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.22 -21.14 72.08 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.609 2.206 . . . . 0.0 112.555 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -56.61 -34.52 67.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.993 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.63 35.09 7.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.572 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -90.03 -51.39 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.0 110.914 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.75 -33.99 1.26 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.38 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -88.06 150.02 23.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -62.41 171.11 2.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.479 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.474 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -47.82 -70.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -24.09 19.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 111.014 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -93.39 13.27 22.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.307 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.2 t -150.14 -75.66 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.809 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.9 m80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 111.322 -179.522 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.523 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.7 ttt180 -47.0 -28.37 1.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -87.22 0.68 54.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -96.89 145.37 29.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.651 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -42.19 118.33 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.096 2.531 . . . . 0.0 112.503 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.418 ' H ' ' HA ' ' A' ' 15' ' ' LYS . 1.8 t -40.21 135.53 1.4 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.544 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.79 -21.82 37.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.52 2.147 . . . . 0.0 112.695 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.5 p -55.51 -29.09 58.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.763 0.316 . . . . 0.0 111.08 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.72 33.31 8.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.526 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -90.05 -32.15 16.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.361 . . . . 0.0 110.953 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.72 -31.75 4.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.487 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 17.1 mttt -87.85 166.3 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.328 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -86.04 161.47 18.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.672 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.523 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -43.35 -63.14 0.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.784 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.46 -25.63 2.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.701 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -89.96 -43.42 10.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.958 0.408 . . . . 0.0 111.391 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.3 t -98.86 -112.56 0.16 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.723 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.7 m80 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.682 0.277 . . . . 0.0 111.566 -179.326 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.463 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.476 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.2 ttt180 -46.13 -28.72 1.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -84.95 0.39 51.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -101.69 145.74 31.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.678 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.8 Cg_endo -44.15 119.94 2.28 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.99 2.46 . . . . 0.0 112.581 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -37.67 135.62 0.76 Allowed Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.694 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.35 -25.9 80.0 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.574 2.182 . . . . 0.0 112.449 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.4 p -57.84 -39.41 77.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.947 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.21 41.67 5.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.631 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.11 -42.29 11.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.38 -36.68 1.35 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.383 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -90.55 164.54 14.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.319 . . . . 0.0 110.739 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -72.74 -178.07 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.536 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -57.78 -68.05 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.025 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -18.88 12.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.444 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 2.3 mm100 -89.44 -29.6 18.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.6 t -107.04 -85.78 0.5 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.007 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.8 m80 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.72 0.295 . . . . 0.0 111.311 -179.285 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -34.99 -31.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -66.26 -3.54 6.02 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.9 t70 -102.14 144.81 29.33 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.655 0.264 . . . . 0.0 110.513 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -47.58 121.38 5.53 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.83 2.353 . . . . 0.0 112.302 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 t -36.52 134.31 0.61 Allowed Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.696 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.51 -20.22 69.24 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.561 2.174 . . . . 0.0 112.744 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.4 p -57.17 -33.86 67.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.834 0.35 . . . . 0.0 110.957 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.31 33.4 6.88 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.577 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 t -90.2 -44.03 10.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.04 -28.43 2.93 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.472 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -89.65 156.23 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.822 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HB2' ' HG3' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -74.21 160.96 30.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.57 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.518 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -45.88 -60.21 2.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.64 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -51.83 -25.49 7.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.641 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.412 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 1.1 mt-30 -92.28 -35.6 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 0.0 111.247 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 t -102.31 -120.15 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.325 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.5 m80 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.762 0.315 . . . . 0.0 111.303 -179.548 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.641 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.492 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -36.64 -30.08 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -70.39 0.1 7.2 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.0 t70 -108.94 145.12 31.04 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-O 120.67 0.271 . . . . 0.0 110.701 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.3 Cg_endo -47.3 122.88 7.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.962 2.441 . . . . 0.0 112.705 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -38.41 135.71 0.89 Allowed Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.576 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.34 -24.11 75.61 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.55 2.167 . . . . 0.0 112.625 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.5 p -58.75 -30.06 67.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.77 38.66 8.59 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.546 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.4 m -90.01 -32.88 16.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.96 -40.1 1.67 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.56 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 12.0 mttt -85.25 166.11 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.767 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -74.58 -177.14 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.341 179.601 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.492 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -60.97 -58.41 8.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.942 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -63.14 -26.19 68.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.945 0.402 . . . . 0.0 110.791 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 1.5 mt-30 -92.71 15.01 15.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.25 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 t -150.02 -78.73 0.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.391 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.1 m80 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.643 179.838 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.697 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.512 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.52 -30.48 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.96 0.32 6.14 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -106.42 147.15 34.4 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.76 0.314 . . . . 0.0 110.736 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 71.3 Cg_exo -48.6 122.71 8.32 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.657 2.238 . . . . 0.0 112.363 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.1 t -39.48 133.74 1.26 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.576 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 -16.25 54.35 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.541 2.161 . . . . 0.0 112.836 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.5 p -58.06 -29.2 65.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.757 0.313 . . . . 0.0 111.031 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.19 30.81 10.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.55 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 m -90.18 -50.61 5.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 0.0 110.967 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.39 -27.92 2.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -88.91 156.47 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -73.28 162.54 29.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.484 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.512 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.45 -62.28 1.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.3 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -25.12 9.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.401 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -90.84 -28.49 18.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 111.158 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.0 t -111.62 -120.07 0.29 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.207 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.5 m80 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.755 0.312 . . . . 0.0 111.375 -179.526 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.499 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.51 -30.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -72.26 0.66 9.32 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.5 t70 -107.16 145.31 30.9 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.681 0.277 . . . . 0.0 110.749 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.0 Cg_endo -46.2 122.86 5.85 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.853 2.369 . . . . 0.0 112.554 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -40.02 135.5 1.35 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.656 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.92 -22.95 74.16 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.59 2.194 . . . . 0.0 112.581 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.7 p -59.1 -31.41 68.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 111.003 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.76 36.74 7.69 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.56 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -90.01 -31.41 17.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.985 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.51 -39.56 1.91 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.375 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.43 154.32 21.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 110.837 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.482 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -71.62 168.66 17.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.431 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -46.27 -61.83 1.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.004 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -56.7 -29.34 62.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.667 -179.378 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.482 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 7.8 mm100 -98.19 19.72 13.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.586 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.6 t -150.39 -80.54 0.12 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.577 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.7 m80 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.752 179.781 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.0 ttt180 -45.61 -28.94 1.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -86.38 0.39 54.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.603 0.239 . . . . 0.0 111.636 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.66 145.56 30.12 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.538 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.1 Cg_endo -43.54 118.86 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.016 2.477 . . . . 0.0 112.585 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.9 t -38.88 135.32 1.0 Allowed Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.55 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.13 -20.39 67.64 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.574 2.183 . . . . 0.0 112.544 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.2 p -57.64 -29.18 64.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.349 . . . . 0.0 111.022 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.93 32.42 21.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.721 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -90.23 -29.77 17.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.927 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.46 -29.04 5.36 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.301 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -86.12 156.91 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.673 0.273 . . . . 0.0 110.791 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -71.85 -178.51 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.407 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -64.74 -62.76 1.38 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.834 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -55.57 -28.29 54.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.956 0.408 . . . . 0.0 110.811 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.68 7.39 36.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.299 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 t -149.97 -120.03 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.965 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.6 m80 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.811 0.339 . . . . 0.0 110.91 -179.925 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.513 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -36.92 -29.94 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -178.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.99 0.24 9.87 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.7 t70 -106.88 145.21 30.64 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-O 120.712 0.291 . . . . 0.0 110.704 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.1 Cg_endo -46.52 122.26 5.57 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.9 2.4 . . . . 0.0 112.442 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -39.08 134.64 1.08 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.538 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.92 -19.47 64.0 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.612 2.208 . . . . 0.0 112.562 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -55.53 -29.87 59.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.018 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.02 33.28 9.04 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.556 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -89.8 -59.26 2.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.33 -28.61 0.78 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.607 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.05 155.55 17.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -68.07 166.46 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.522 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.513 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -45.86 -68.83 0.16 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.145 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -24.5 16.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -96.44 13.69 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.303 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 t -150.22 -74.85 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.836 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.7 m80 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.714 0.292 . . . . 0.0 111.316 -179.514 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 1.7 ttt85 -46.93 -28.05 1.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -86.9 0.87 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.717 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -99.42 145.54 30.24 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.574 0.226 . . . . 0.0 110.648 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.2 Cg_endo -42.62 119.65 1.5 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.013 2.475 . . . . 0.0 112.451 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -39.2 135.24 1.09 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.57 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.94 -22.53 74.48 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.558 2.172 . . . . 0.0 112.591 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -56.61 -30.58 63.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.36 36.12 10.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.576 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -90.02 -48.42 7.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.911 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.31 -28.23 1.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.406 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -92.83 152.25 19.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -72.8 163.13 28.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.668 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -45.97 -60.93 1.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.661 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.402 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 2.8 pttt -49.43 -26.54 3.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.936 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.433 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 10.7 mm-40 -92.91 -43.29 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.546 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.2 t -91.88 -120.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.723 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.1 m80 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.713 0.292 . . . . 0.0 111.505 -179.338 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.527 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -35.71 -30.52 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.796 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -70.49 0.14 7.3 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.4 t70 -104.71 145.34 30.51 Favored Pre-proline 0 C--O 1.232 0.16 0 CA-C-O 120.629 0.252 . . . . 0.0 110.632 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.2 Cg_endo -46.94 121.54 5.18 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.903 2.402 . . . . 0.0 112.35 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -37.75 135.19 0.79 Allowed Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.603 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.23 -23.49 59.61 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.519 2.146 . . . . 0.0 112.658 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.5 p -57.01 -29.72 63.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.93 37.46 6.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.523 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.8 p -90.14 -34.62 15.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.03 -26.14 5.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.459 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 1.2 mptt -96.53 160.73 14.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -73.32 166.12 23.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.521 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.527 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -49.09 -68.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.352 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.24 -24.63 2.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.632 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 6.9 mm100 -89.76 -27.34 20.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.63 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' LYS . 12.0 t -110.04 -80.98 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.0 m80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.491 -179.34 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.568 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.499 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 1.1 ttt85 -46.4 -28.6 1.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -87.0 1.1 53.94 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -97.77 145.32 29.54 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.701 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -42.58 118.83 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.067 2.511 . . . . 0.0 112.487 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -40.29 135.19 1.45 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.66 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.4 -21.5 66.5 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.533 2.156 . . . . 0.0 112.549 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.6 p -56.37 -30.36 62.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.337 . . . . 0.0 111.009 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.12 33.97 10.24 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.517 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -90.07 -35.55 15.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.814 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.38 -28.33 4.29 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.451 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -89.11 163.42 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.463 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -85.74 160.15 19.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 179.717 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -43.65 -62.16 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.751 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -47.97 -27.37 2.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.003 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.463 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 2.5 tt0 -94.6 -36.76 11.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.65 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 t -99.85 -120.13 0.15 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.538 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.0 m80 . . . . . 0 C--O 1.231 0.108 0 O-C-N 122.274 -0.266 . . . . 0.0 111.654 -179.296 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.447 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.479 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 14.2 ttp180 -47.83 -28.04 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -84.22 0.78 47.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.616 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -101.5 145.19 30.02 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.64 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -42.42 120.0 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.092 2.528 . . . . 0.0 112.39 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -40.21 135.67 1.39 Allowed Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.478 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.66 -20.26 49.77 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.546 2.164 . . . . 0.0 112.604 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.0 p -60.04 -31.33 69.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.87 0.367 . . . . 0.0 110.893 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.57 35.53 13.71 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.57 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -90.18 -44.92 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.909 0.385 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.74 -29.14 2.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.434 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.73 134.17 34.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -55.8 166.18 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.759 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.479 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -45.9 -61.06 1.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.584 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HG2' ' HG3' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -52.41 -35.41 51.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.534 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.443 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 9.1 mm100 -90.61 13.73 15.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.573 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 t -150.36 -120.6 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.545 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.3 m80 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.69 0.281 . . . . 0.0 111.44 -179.612 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.856 0.36 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 3' ' ' GLY . 14.8 p -123.45 158.87 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.195 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.503 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -81.24 84.65 1.43 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.436 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.512 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -37.12 -29.54 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -70.49 0.15 7.26 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 3' ' ' GLY . 6.0 t70 -108.43 144.88 30.4 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.59 0.233 . . . . 0.0 110.578 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.3 Cg_endo -47.38 123.8 8.4 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.692 2.261 . . . . 0.0 112.314 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 t -38.66 134.67 0.98 Allowed Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.719 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.1 -21.41 65.53 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.576 2.184 . . . . 0.0 112.556 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -57.64 -30.25 65.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 0.0 111.031 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.34 34.69 11.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.522 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.7 p -90.15 -41.21 11.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.14 -28.72 2.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.459 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 153.16 20.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.707 0.289 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -74.99 163.53 27.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.56 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.512 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.0 -59.85 2.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.947 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.402 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -50.34 -24.67 3.14 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.049 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.476 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -98.11 -28.52 13.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.683 0.278 . . . . 0.0 111.718 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.0 t -107.19 -120.52 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.866 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -60.8 -38.52 85.65 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.703 0.287 . . . . 0.0 111.749 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -47.77 -27.52 4.75 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.837 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.858 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.781 0.324 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.446 ' CG1' ' CD2' ' A' ' 16' ' ' TYR . 12.9 p -114.74 149.27 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.297 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.19 81.16 0.58 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.283 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.498 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -34.72 -33.08 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.28 -7.82 4.86 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -99.06 144.79 28.86 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.634 0.254 . . . . 0.0 110.657 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.4 Cg_endo -48.54 120.2 4.94 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.736 2.29 . . . . 0.0 112.306 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 t -34.57 133.72 0.41 Allowed Pre-proline 0 N--CA 1.467 0.385 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.742 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.73 -17.64 55.95 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.642 2.228 . . . . 0.0 112.72 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 p -57.18 -28.13 62.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.0 111.014 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.13 30.69 16.31 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.58 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.8 p -90.33 -49.16 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.828 0.347 . . . . 0.0 110.925 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.85 -27.13 2.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.422 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -88.27 150.56 23.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.807 0.336 . . . . 0.0 110.948 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -67.5 161.61 25.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.558 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.498 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -47.53 -66.29 0.43 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.302 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.83 -25.78 4.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.31 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -89.81 -19.67 24.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.358 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 t -119.05 -119.73 0.31 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.746 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -67.31 -22.54 65.62 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.3 -27.22 5.39 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.835 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.871 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 3' ' ' GLY . 14.1 p -120.03 158.53 21.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.504 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -76.76 81.99 1.1 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.412 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.509 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -36.79 -29.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.409 ' O ' ' ND2' ' A' ' 5' ' ' ASN . 0.2 OUTLIER -69.49 -0.96 7.37 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.3 t70 -106.16 145.18 30.43 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.608 0.242 . . . . 0.0 110.633 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.3 Cg_endo -47.2 122.58 6.61 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.862 2.375 . . . . 0.0 112.284 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 t -38.77 134.14 1.02 Allowed Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.653 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.14 -19.68 66.36 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.599 2.199 . . . . 0.0 112.752 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.0 p -55.68 -29.23 59.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.79 0.329 . . . . 0.0 111.057 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.52 32.0 9.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.611 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.8 p -90.07 -49.38 6.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.5 -27.91 2.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.466 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -89.97 154.09 20.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -70.56 161.93 29.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.592 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.509 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -46.49 -63.56 0.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.503 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.73 -25.68 4.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.582 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -89.99 -34.01 16.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.376 . . . . 0.0 111.156 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.9 t -104.54 -119.96 0.21 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.29 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -53.18 -46.07 68.81 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.745 0.307 . . . . 0.0 111.291 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.35 -44.79 65.92 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.54 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.884 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.802 0.334 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.478 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.2 p -102.96 147.47 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.49 95.07 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.481 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.521 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 34.4 ttt180 -47.12 -27.95 1.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -85.75 0.48 52.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -100.55 145.29 30.06 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.582 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.2 Cg_endo -42.92 119.64 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.041 2.494 . . . . 0.0 112.441 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -38.04 135.11 0.85 Allowed Pre-proline 0 N--CA 1.465 0.291 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.668 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.7 -21.92 71.26 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.559 2.173 . . . . 0.0 112.648 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.7 p -57.45 -38.08 73.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.769 0.319 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.83 33.63 6.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.64 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.25 -29.72 17.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.77 -28.05 6.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.41 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 151.26 22.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.332 . . . . 0.0 110.77 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -71.15 166.5 21.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.538 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.521 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -48.7 -64.59 0.76 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.448 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -25.36 8.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.385 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -89.76 -26.83 20.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.272 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 15' ' ' LYS . 8.7 t -113.65 -120.05 0.3 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.263 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -59.13 -43.51 91.97 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.731 0.301 . . . . 0.0 111.191 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -54.02 -23.43 23.87 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.684 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.959 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.855 0.359 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.479 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.9 p -114.86 146.79 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.18 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.79 96.56 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.327 -0.94 . . . . 0.0 111.275 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.508 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 4.1 ttt85 -47.41 -27.9 1.88 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -87.08 0.7 54.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.687 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.07 146.47 31.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.703 0.287 . . . . 0.0 110.591 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 98.7 Cg_exo -42.61 119.08 1.31 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.749 2.299 . . . . 0.0 112.607 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 t -41.08 134.49 1.79 Allowed Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.546 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.01 -18.73 64.82 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.597 2.198 . . . . 0.0 112.799 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.3 p -55.94 -26.23 46.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.795 0.331 . . . . 0.0 111.17 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.07 28.71 22.38 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.675 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.4 p -90.33 -33.36 16.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.781 0.324 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.19 -28.41 6.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.38 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -83.81 152.68 24.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.332 . . . . 0.0 110.769 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -72.41 163.49 27.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.672 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -47.86 -61.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.159 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -54.37 -30.94 53.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.018 0.437 . . . . 0.0 110.891 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.47 8.3 34.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.419 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.08 -120.34 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.107 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -59.17 -40.59 86.11 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.73 0.3 . . . . 0.0 110.958 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.09 -40.74 93.99 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.378 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.328 -0.844 . . . . 0.0 110.959 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.726 0.298 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.475 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.8 p -123.92 147.21 28.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.187 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.24 94.74 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.244 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.502 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 12.6 ttp-105 -47.21 -27.73 1.6 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -85.06 0.65 50.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.67 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.1 146.46 31.75 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.698 0.285 . . . . 0.0 110.728 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 96.3 Cg_exo -43.05 118.81 1.38 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.739 2.293 . . . . 0.0 112.655 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 t -40.26 134.44 1.49 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.516 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.22 -16.72 52.72 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.608 2.206 . . . . 0.0 112.777 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.6 p -56.76 -26.19 56.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 111.159 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.83 28.52 26.05 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.592 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.0 m -90.27 -40.51 12.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.05 -27.48 4.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.287 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -85.19 149.02 25.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.805 0.336 . . . . 0.0 110.771 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -68.51 165.95 17.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.768 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.502 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -49.79 -63.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.234 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 0.9 OUTLIER -52.17 -30.73 28.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.907 0.384 . . . . 0.0 110.985 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.03 8.69 31.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.571 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.2 -120.28 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.489 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -66.37 -27.08 67.6 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 122.328 -0.233 . . . . 0.0 111.575 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.28 -26.22 9.16 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.787 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.886 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.3 mmtm . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.85 0.357 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 12.7 p -93.54 144.35 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.3 97.22 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.363 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.475 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 38.1 ttt180 -48.24 -27.89 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -86.11 0.35 53.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.7 0.286 . . . . 0.0 111.615 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -100.75 145.61 30.65 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.594 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.2 Cg_endo -42.57 119.46 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.082 2.522 . . . . 0.0 112.416 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 t -38.67 135.25 0.96 Allowed Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.528 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.97 -20.91 38.78 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.569 2.179 . . . . 0.0 112.632 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -58.94 -28.35 66.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.772 0.32 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.05 34.08 24.88 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.636 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -90.14 -37.96 13.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.64 -27.85 3.47 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.478 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -89.33 140.29 29.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 0.0 110.917 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.26 165.52 3.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.723 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.475 ' HB3' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.37 -65.71 0.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.263 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -24.58 9.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.252 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -89.83 -18.34 26.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.263 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 t -121.96 -120.1 0.29 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.542 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -66.73 -30.32 70.52 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 122.25 -0.281 . . . . 0.0 111.713 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.44 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -49.37 -26.45 6.94 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.793 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.912 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.765 0.316 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.492 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 9.7 p -117.11 150.26 19.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.15 94.82 0.1 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.318 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.474 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -46.97 -28.88 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -84.73 0.83 49.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.649 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.18 145.25 30.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.635 0.255 . . . . 0.0 110.694 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -43.47 119.66 1.86 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.021 2.481 . . . . 0.0 112.444 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -38.67 134.78 0.98 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.619 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.22 -21.14 72.08 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.609 2.206 . . . . 0.0 112.555 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -56.61 -34.52 67.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.993 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.63 35.09 7.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.572 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -90.03 -51.39 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.0 110.914 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.75 -33.99 1.26 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.38 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -88.06 150.02 23.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -62.41 171.11 2.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.479 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.492 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -47.82 -70.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -24.09 19.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 111.014 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -93.39 13.27 22.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.307 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.2 t -150.14 -75.66 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.809 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -114.18 -35.21 5.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 111.322 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.8 -25.12 14.84 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.666 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.798 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.2 mttm . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.855 0.36 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.494 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 12.8 p -111.89 144.18 20.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.172 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.15 96.37 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.391 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.523 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.7 ttt180 -47.0 -28.37 1.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -87.22 0.68 54.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -96.89 145.37 29.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.651 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -42.19 118.33 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.096 2.531 . . . . 0.0 112.503 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.418 ' H ' ' HA ' ' A' ' 15' ' ' LYS . 1.8 t -40.21 135.53 1.4 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.544 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.79 -21.82 37.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.52 2.147 . . . . 0.0 112.695 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.5 p -55.51 -29.09 58.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.763 0.316 . . . . 0.0 111.08 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.72 33.31 8.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.526 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -90.05 -32.15 16.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.361 . . . . 0.0 110.953 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.72 -31.75 4.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.487 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 17.1 mttt -87.85 166.3 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.328 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -86.04 161.47 18.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.672 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.523 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -43.35 -63.14 0.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.784 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.46 -25.63 2.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.701 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -89.96 -43.42 10.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.958 0.408 . . . . 0.0 111.391 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.3 t -98.86 -112.56 0.16 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.723 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -55.11 -53.45 55.72 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.682 0.277 . . . . 0.0 111.566 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.02 -28.09 3.84 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.941 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.3 mptt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.807 0.337 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.506 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.3 p -110.9 143.77 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.222 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.41 96.74 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.289 -0.957 . . . . 0.0 111.322 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.476 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.2 ttt180 -46.13 -28.72 1.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -84.95 0.39 51.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -101.69 145.74 31.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.678 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.8 Cg_endo -44.15 119.94 2.28 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.99 2.46 . . . . 0.0 112.581 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -37.67 135.62 0.76 Allowed Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.694 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.35 -25.9 80.0 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.574 2.182 . . . . 0.0 112.449 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.4 p -57.84 -39.41 77.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.947 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.21 41.67 5.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.631 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.11 -42.29 11.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.38 -36.68 1.35 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.383 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -90.55 164.54 14.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.319 . . . . 0.0 110.739 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -72.74 -178.07 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.536 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.506 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.4 OUTLIER -57.78 -68.05 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.025 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -18.88 12.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.444 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 2.3 mm100 -89.44 -29.6 18.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.6 t -107.04 -85.78 0.5 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.007 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -87.7 -51.47 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.72 0.295 . . . . 0.0 111.311 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . -47.2 -30.91 5.86 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.73 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.005 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.825 0.345 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.455 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.5 p -107.58 149.94 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.256 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -71.53 80.81 0.52 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.269 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -34.99 -31.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -66.26 -3.54 6.02 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.9 t70 -102.14 144.81 29.33 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.655 0.264 . . . . 0.0 110.513 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -47.58 121.38 5.53 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.83 2.353 . . . . 0.0 112.302 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 t -36.52 134.31 0.61 Allowed Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.696 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.51 -20.22 69.24 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.561 2.174 . . . . 0.0 112.744 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.4 p -57.17 -33.86 67.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.834 0.35 . . . . 0.0 110.957 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.31 33.4 6.88 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.577 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 t -90.2 -44.03 10.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.04 -28.43 2.93 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.472 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -89.65 156.23 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.822 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HB2' ' HG3' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -74.21 160.96 30.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.57 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.518 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -45.88 -60.21 2.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.64 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -51.83 -25.49 7.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.641 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.412 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 1.1 mt-30 -92.28 -35.6 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 0.0 111.247 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 t -102.31 -120.15 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.325 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -56.72 -47.77 79.22 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.762 0.315 . . . . 0.0 111.303 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -52.54 -24.47 17.7 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.743 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.868 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.85 0.357 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 3' ' ' GLY . 14.0 p -119.01 158.92 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.501 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -82.7 85.97 1.48 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.398 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.492 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -36.64 -30.08 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -70.39 0.1 7.2 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.0 t70 -108.94 145.12 31.04 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-O 120.67 0.271 . . . . 0.0 110.701 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.3 Cg_endo -47.3 122.88 7.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.962 2.441 . . . . 0.0 112.705 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -38.41 135.71 0.89 Allowed Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.576 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.34 -24.11 75.61 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.55 2.167 . . . . 0.0 112.625 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.5 p -58.75 -30.06 67.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.77 38.66 8.59 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.546 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.4 m -90.01 -32.88 16.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.96 -40.1 1.67 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.56 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 12.0 mttt -85.25 166.11 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.767 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -74.58 -177.14 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.341 179.601 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.492 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -60.97 -58.41 8.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.942 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -63.14 -26.19 68.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.945 0.402 . . . . 0.0 110.791 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 1.5 mt-30 -92.71 15.01 15.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.25 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 t -150.02 -78.73 0.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.391 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 22' ' ' ARG . 28.1 m80 -105.64 -86.14 0.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.643 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.456 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . 52.22 -84.06 0.01 OUTLIER Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.927 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 20' ' ' HIS . 4.2 mtt180 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.79 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.762 0.315 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.502 HG22 ' N ' ' A' ' 3' ' ' GLY . 14.7 p -102.81 158.28 4.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.502 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -78.81 84.36 1.22 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.337 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.512 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.52 -30.48 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.96 0.32 6.14 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -106.42 147.15 34.4 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.76 0.314 . . . . 0.0 110.736 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 71.3 Cg_exo -48.6 122.71 8.32 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.657 2.238 . . . . 0.0 112.363 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.1 t -39.48 133.74 1.26 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.576 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 -16.25 54.35 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.541 2.161 . . . . 0.0 112.836 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.5 p -58.06 -29.2 65.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.757 0.313 . . . . 0.0 111.031 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.19 30.81 10.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.55 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 m -90.18 -50.61 5.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 0.0 110.967 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.39 -27.92 2.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -88.91 156.47 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -73.28 162.54 29.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.484 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.512 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.45 -62.28 1.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.3 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -25.12 9.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.401 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -90.84 -28.49 18.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 111.158 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.0 t -111.62 -120.07 0.29 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.207 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -58.09 -45.0 87.91 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.755 0.312 . . . . 0.0 111.375 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.437 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -51.89 -25.04 15.31 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.765 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.939 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.6 mttt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.726 0.298 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 3' ' ' GLY . 13.9 p -118.14 158.76 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.251 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.498 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -80.15 84.1 1.36 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.249 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.499 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.51 -30.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -72.26 0.66 9.32 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.5 t70 -107.16 145.31 30.9 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.681 0.277 . . . . 0.0 110.749 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.0 Cg_endo -46.2 122.86 5.85 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.853 2.369 . . . . 0.0 112.554 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -40.02 135.5 1.35 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.656 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.92 -22.95 74.16 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.59 2.194 . . . . 0.0 112.581 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.7 p -59.1 -31.41 68.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 111.003 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.76 36.74 7.69 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.56 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -90.01 -31.41 17.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.985 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.51 -39.56 1.91 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.375 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.43 154.32 21.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 110.837 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.482 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -71.62 168.66 17.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.431 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -46.27 -61.83 1.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.004 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -56.7 -29.34 62.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.667 -179.378 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.482 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 7.8 mm100 -98.19 19.72 13.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.586 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.6 t -150.39 -80.54 0.12 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.577 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.484 ' O ' ' N ' ' A' ' 22' ' ' ARG . 24.7 m80 -105.72 -88.34 0.44 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.752 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.467 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . 52.81 -83.77 0.01 OUTLIER Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.825 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 20' ' ' HIS . 6.3 mtt-85 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.912 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.3 mttt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.795 0.331 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.494 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 11.8 p -88.3 145.79 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.19 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.51 96.71 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.073 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.0 ttt180 -45.61 -28.94 1.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -86.38 0.39 54.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.603 0.239 . . . . 0.0 111.636 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.66 145.56 30.12 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.538 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.1 Cg_endo -43.54 118.86 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.016 2.477 . . . . 0.0 112.585 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.9 t -38.88 135.32 1.0 Allowed Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.55 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.13 -20.39 67.64 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.574 2.183 . . . . 0.0 112.544 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.2 p -57.64 -29.18 64.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.349 . . . . 0.0 111.022 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.93 32.42 21.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.721 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -90.23 -29.77 17.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.927 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.46 -29.04 5.36 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.301 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -86.12 156.91 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.673 0.273 . . . . 0.0 110.791 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -71.85 -178.51 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.407 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -64.74 -62.76 1.38 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.834 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -55.57 -28.29 54.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.956 0.408 . . . . 0.0 110.811 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.68 7.39 36.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.299 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 t -149.97 -120.03 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.965 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -59.76 -40.2 87.36 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.811 0.339 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.17 -40.19 95.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.534 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.905 0.383 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 3' ' ' GLY . 14.7 p -109.7 158.63 9.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.214 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.501 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -81.29 84.46 1.44 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.256 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.513 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -36.92 -29.94 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -178.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.99 0.24 9.87 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.7 t70 -106.88 145.21 30.64 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-O 120.712 0.291 . . . . 0.0 110.704 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.1 Cg_endo -46.52 122.26 5.57 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.9 2.4 . . . . 0.0 112.442 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -39.08 134.64 1.08 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.538 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.92 -19.47 64.0 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.612 2.208 . . . . 0.0 112.562 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -55.53 -29.87 59.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.018 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.02 33.28 9.04 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.556 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -89.8 -59.26 2.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.33 -28.61 0.78 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.607 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.05 155.55 17.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -68.07 166.46 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.522 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.513 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -45.86 -68.83 0.16 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.145 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -24.5 16.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -96.44 13.69 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.303 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 t -150.22 -74.85 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.836 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -117.84 -36.1 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.714 0.292 . . . . 0.0 111.316 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.454 ' CA ' ' CD2' ' A' ' 16' ' ' TYR . . . -47.68 -27.93 4.85 Favored Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.844 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.817 0.341 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.487 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 11.6 p -101.04 149.41 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.27 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.08 93.82 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.263 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 1.7 ttt85 -46.93 -28.05 1.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -86.9 0.87 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.717 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -99.42 145.54 30.24 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.574 0.226 . . . . 0.0 110.648 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.2 Cg_endo -42.62 119.65 1.5 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.013 2.475 . . . . 0.0 112.451 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -39.2 135.24 1.09 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.57 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.94 -22.53 74.48 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.558 2.172 . . . . 0.0 112.591 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -56.61 -30.58 63.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.36 36.12 10.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.576 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -90.02 -48.42 7.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.911 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.31 -28.23 1.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.406 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -92.83 152.25 19.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -72.8 163.13 28.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.668 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -45.97 -60.93 1.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.661 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.402 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 2.8 pttt -49.43 -26.54 3.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.936 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.433 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 10.7 mm-40 -92.91 -43.29 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.546 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.2 t -91.88 -120.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.723 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -59.63 -45.6 91.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.713 0.292 . . . . 0.0 111.505 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.435 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -50.98 -25.45 9.82 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.844 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.862 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.9 mtmm . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.791 0.329 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.4 p -117.66 152.56 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.204 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -72.78 80.78 0.66 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.253 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.527 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -35.71 -30.52 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -70.49 0.14 7.3 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.4 t70 -104.71 145.34 30.51 Favored Pre-proline 0 C--O 1.232 0.16 0 CA-C-O 120.629 0.252 . . . . 0.0 110.632 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.2 Cg_endo -46.94 121.54 5.18 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.903 2.402 . . . . 0.0 112.35 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -37.75 135.19 0.79 Allowed Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.603 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.23 -23.49 59.61 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.519 2.146 . . . . 0.0 112.658 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.5 p -57.01 -29.72 63.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.93 37.46 6.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.523 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.8 p -90.14 -34.62 15.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.03 -26.14 5.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.459 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 1.2 mptt -96.53 160.73 14.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -73.32 166.12 23.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.521 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.527 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -49.09 -68.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.352 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.426 ' HA ' ' N ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -50.24 -24.63 2.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.632 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 6.9 mm100 -89.76 -27.34 20.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.63 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' LYS . 12.0 t -110.04 -80.98 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -100.28 -47.39 4.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.491 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' HA3' ' CD2' ' A' ' 16' ' ' TYR . . . -47.05 -28.05 3.87 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.758 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.426 ' N ' ' HA ' ' A' ' 17' ' ' LYS . 6.9 mmt180 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.801 0.334 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.502 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.9 p -84.28 144.99 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.67 96.45 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.279 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.499 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 1.1 ttt85 -46.4 -28.6 1.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -87.0 1.1 53.94 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -97.77 145.32 29.54 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.701 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -42.58 118.83 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.067 2.511 . . . . 0.0 112.487 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -40.29 135.19 1.45 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.66 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.4 -21.5 66.5 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.533 2.156 . . . . 0.0 112.549 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.6 p -56.37 -30.36 62.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.337 . . . . 0.0 111.009 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.12 33.97 10.24 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.517 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -90.07 -35.55 15.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.814 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.38 -28.33 4.29 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.451 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -89.11 163.42 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.463 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -85.74 160.15 19.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 179.717 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.502 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -43.65 -62.16 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.751 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -47.97 -27.37 2.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.003 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.463 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 2.5 tt0 -94.6 -36.76 11.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.65 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 t -99.85 -120.13 0.15 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.538 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -57.76 -47.3 82.88 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 122.274 -0.266 . . . . 0.0 111.654 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.419 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -47.1 -45.26 20.25 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.92 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.965 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.916 0.388 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.498 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 12.1 p -102.87 138.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.128 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.29 98.22 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.496 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.479 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 14.2 ttp180 -47.83 -28.04 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -84.22 0.78 47.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.616 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -101.5 145.19 30.02 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.64 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -42.42 120.0 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.092 2.528 . . . . 0.0 112.39 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -40.21 135.67 1.39 Allowed Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.478 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.66 -20.26 49.77 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.546 2.164 . . . . 0.0 112.604 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.0 p -60.04 -31.33 69.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.87 0.367 . . . . 0.0 110.893 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.57 35.53 13.71 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.57 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -90.18 -44.92 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.909 0.385 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.74 -29.14 2.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.434 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.73 134.17 34.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -55.8 166.18 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.759 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.498 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -45.9 -61.06 1.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.584 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HG2' ' HG3' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -52.41 -35.41 51.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.534 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.443 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 9.1 mm100 -90.61 13.73 15.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.573 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 t -150.36 -120.6 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.545 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -67.4 -28.27 67.78 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.69 0.281 . . . . 0.0 111.44 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.08 -24.44 20.85 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.76 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.447 -0.633 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.512 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -37.12 -29.54 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -70.49 0.15 7.26 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 3' ' ' GLY . 6.0 t70 -108.43 144.88 30.4 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.59 0.233 . . . . 0.0 110.578 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.3 Cg_endo -47.38 123.8 8.4 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.692 2.261 . . . . 0.0 112.314 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 t -38.66 134.67 0.98 Allowed Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.719 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.1 -21.41 65.53 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.576 2.184 . . . . 0.0 112.556 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -57.64 -30.25 65.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 0.0 111.031 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.34 34.69 11.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.522 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.7 p -90.15 -41.21 11.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.14 -28.72 2.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.459 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 153.16 20.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.707 0.289 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -74.99 163.53 27.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.56 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.512 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.0 -59.85 2.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.947 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.402 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -50.34 -24.67 3.14 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.049 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.476 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -98.11 -28.52 13.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.683 0.278 . . . . 0.0 111.718 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.0 t -107.19 -120.52 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.866 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.8 m80 . . . . . 0 N--CA 1.461 0.122 0 CA-C-O 120.703 0.287 . . . . 0.0 111.749 -179.169 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.498 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -34.72 -33.08 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.28 -7.82 4.86 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -99.06 144.79 28.86 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.634 0.254 . . . . 0.0 110.657 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.4 Cg_endo -48.54 120.2 4.94 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.736 2.29 . . . . 0.0 112.306 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 t -34.57 133.72 0.41 Allowed Pre-proline 0 N--CA 1.467 0.385 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.742 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.73 -17.64 55.95 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.642 2.228 . . . . 0.0 112.72 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 p -57.18 -28.13 62.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.0 111.014 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.13 30.69 16.31 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.58 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.8 p -90.33 -49.16 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.828 0.347 . . . . 0.0 110.925 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.85 -27.13 2.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.422 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -88.27 150.56 23.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.807 0.336 . . . . 0.0 110.948 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -67.5 161.61 25.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.558 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.498 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -47.53 -66.29 0.43 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.302 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.83 -25.78 4.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.31 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -89.81 -19.67 24.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.358 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 t -119.05 -119.73 0.31 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.746 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.0 m80 . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.089 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.68 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.509 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -36.79 -29.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -69.49 -0.96 7.37 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.3 t70 -106.16 145.18 30.43 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.608 0.242 . . . . 0.0 110.633 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.3 Cg_endo -47.2 122.58 6.61 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.862 2.375 . . . . 0.0 112.284 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 t -38.77 134.14 1.02 Allowed Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.653 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.14 -19.68 66.36 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.599 2.199 . . . . 0.0 112.752 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.0 p -55.68 -29.23 59.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.79 0.329 . . . . 0.0 111.057 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.52 32.0 9.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.611 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.8 p -90.07 -49.38 6.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.5 -27.91 2.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.466 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -89.97 154.09 20.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -70.56 161.93 29.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.592 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.509 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -46.49 -63.56 0.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.503 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.73 -25.68 4.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.582 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -89.99 -34.01 16.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.376 . . . . 0.0 111.156 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.9 t -104.54 -119.96 0.21 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.29 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.1 m80 . . . . . 0 N--CA 1.461 0.101 0 CA-C-O 120.745 0.307 . . . . 0.0 111.291 -179.603 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.521 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 34.4 ttt180 -47.12 -27.95 1.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -85.75 0.48 52.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -100.55 145.29 30.06 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.582 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.2 Cg_endo -42.92 119.64 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.041 2.494 . . . . 0.0 112.441 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -38.04 135.11 0.85 Allowed Pre-proline 0 N--CA 1.465 0.291 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.668 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.7 -21.92 71.26 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.559 2.173 . . . . 0.0 112.648 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.7 p -57.45 -38.08 73.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.769 0.319 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.83 33.63 6.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.64 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.25 -29.72 17.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.77 -28.05 6.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.41 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 151.26 22.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.332 . . . . 0.0 110.77 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -71.15 166.5 21.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.538 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.521 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -48.7 -64.59 0.76 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.448 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -25.36 8.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.385 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -89.76 -26.83 20.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.272 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 15' ' ' LYS . 8.7 t -113.65 -120.05 0.3 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.263 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.4 m80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.731 0.301 . . . . 0.0 111.191 -179.557 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.508 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 4.1 ttt85 -47.41 -27.9 1.88 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -87.08 0.7 54.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.687 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.07 146.47 31.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.703 0.287 . . . . 0.0 110.591 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 98.7 Cg_exo -42.61 119.08 1.31 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.749 2.299 . . . . 0.0 112.607 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 t -41.08 134.49 1.79 Allowed Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.546 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.01 -18.73 64.82 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.597 2.198 . . . . 0.0 112.799 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.3 p -55.94 -26.23 46.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.795 0.331 . . . . 0.0 111.17 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.07 28.71 22.38 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.675 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.4 p -90.33 -33.36 16.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.781 0.324 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.19 -28.41 6.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.38 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -83.81 152.68 24.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.332 . . . . 0.0 110.769 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -72.41 163.49 27.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.672 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -47.86 -61.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.159 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -54.37 -30.94 53.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.018 0.437 . . . . 0.0 110.891 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.47 8.3 34.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.419 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.08 -120.34 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.107 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.5 m80 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.73 0.3 . . . . 0.0 110.958 -179.779 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.51 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.502 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 12.6 ttp-105 -47.21 -27.73 1.6 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -85.06 0.65 50.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.67 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.1 146.46 31.75 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.698 0.285 . . . . 0.0 110.728 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 96.3 Cg_exo -43.05 118.81 1.38 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.739 2.293 . . . . 0.0 112.655 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 t -40.26 134.44 1.49 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.516 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.22 -16.72 52.72 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.608 2.206 . . . . 0.0 112.777 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.6 p -56.76 -26.19 56.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 111.159 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.83 28.52 26.05 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.592 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.0 m -90.27 -40.51 12.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.05 -27.48 4.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.287 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -85.19 149.02 25.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.805 0.336 . . . . 0.0 110.771 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -68.51 165.95 17.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.768 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.502 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -49.79 -63.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.234 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 0.9 OUTLIER -52.17 -30.73 28.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.907 0.384 . . . . 0.0 110.985 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.03 8.69 31.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.571 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.2 -120.28 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.489 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.8 m80 . . . . . 0 C--O 1.233 0.203 0 O-C-N 122.328 -0.233 . . . . 0.0 111.575 -179.295 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.475 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 38.1 ttt180 -48.24 -27.89 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -86.11 0.35 53.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.7 0.286 . . . . 0.0 111.615 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -100.75 145.61 30.65 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.594 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.2 Cg_endo -42.57 119.46 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.082 2.522 . . . . 0.0 112.416 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 t -38.67 135.25 0.96 Allowed Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.528 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.97 -20.91 38.78 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.569 2.179 . . . . 0.0 112.632 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -58.94 -28.35 66.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.772 0.32 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.05 34.08 24.88 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.636 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -90.14 -37.96 13.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.64 -27.85 3.47 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.478 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -89.33 140.29 29.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 0.0 110.917 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.26 165.52 3.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.723 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.475 ' HB3' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.37 -65.71 0.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.263 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -24.58 9.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.252 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -89.83 -18.34 26.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.263 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 t -121.96 -120.1 0.29 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.542 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.4 m80 . . . . . 0 C--O 1.231 0.131 0 O-C-N 122.25 -0.281 . . . . 0.0 111.713 -179.207 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.474 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -46.97 -28.88 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -84.73 0.83 49.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.649 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.18 145.25 30.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.635 0.255 . . . . 0.0 110.694 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -43.47 119.66 1.86 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.021 2.481 . . . . 0.0 112.444 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -38.67 134.78 0.98 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.619 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.22 -21.14 72.08 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.609 2.206 . . . . 0.0 112.555 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -56.61 -34.52 67.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.993 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.63 35.09 7.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.572 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -90.03 -51.39 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.0 110.914 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.75 -33.99 1.26 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.38 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -88.06 150.02 23.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -62.41 171.11 2.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.479 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.474 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -47.82 -70.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -24.09 19.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 111.014 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -93.39 13.27 22.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.307 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.2 t -150.14 -75.66 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.809 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.9 m80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 111.322 -179.522 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.523 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.7 ttt180 -47.0 -28.37 1.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -87.22 0.68 54.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -96.89 145.37 29.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.651 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -42.19 118.33 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.096 2.531 . . . . 0.0 112.503 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.418 ' H ' ' HA ' ' A' ' 15' ' ' LYS . 1.8 t -40.21 135.53 1.4 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.544 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.79 -21.82 37.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.52 2.147 . . . . 0.0 112.695 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.5 p -55.51 -29.09 58.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.763 0.316 . . . . 0.0 111.08 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.72 33.31 8.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.526 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -90.05 -32.15 16.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.361 . . . . 0.0 110.953 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.72 -31.75 4.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.487 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 17.1 mttt -87.85 166.3 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.328 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -86.04 161.47 18.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.672 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.523 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -43.35 -63.14 0.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.784 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.46 -25.63 2.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.701 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -89.96 -43.42 10.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.958 0.408 . . . . 0.0 111.391 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.3 t -98.86 -112.56 0.16 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.723 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.7 m80 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.682 0.277 . . . . 0.0 111.566 -179.326 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.463 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.476 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.2 ttt180 -46.13 -28.72 1.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -84.95 0.39 51.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -101.69 145.74 31.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.678 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.8 Cg_endo -44.15 119.94 2.28 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.99 2.46 . . . . 0.0 112.581 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -37.67 135.62 0.76 Allowed Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.694 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.35 -25.9 80.0 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.574 2.182 . . . . 0.0 112.449 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.4 p -57.84 -39.41 77.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.947 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.21 41.67 5.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.631 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.11 -42.29 11.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.38 -36.68 1.35 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.383 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -90.55 164.54 14.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.319 . . . . 0.0 110.739 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -72.74 -178.07 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.536 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -57.78 -68.05 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.025 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -18.88 12.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.444 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 2.3 mm100 -89.44 -29.6 18.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.6 t -107.04 -85.78 0.5 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.007 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.8 m80 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.72 0.295 . . . . 0.0 111.311 -179.285 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.518 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -34.99 -31.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -66.26 -3.54 6.02 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.9 t70 -102.14 144.81 29.33 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.655 0.264 . . . . 0.0 110.513 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -47.58 121.38 5.53 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.83 2.353 . . . . 0.0 112.302 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 t -36.52 134.31 0.61 Allowed Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.696 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.51 -20.22 69.24 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.561 2.174 . . . . 0.0 112.744 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.4 p -57.17 -33.86 67.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.834 0.35 . . . . 0.0 110.957 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.31 33.4 6.88 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.577 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 t -90.2 -44.03 10.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.04 -28.43 2.93 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.472 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -89.65 156.23 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.822 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HB2' ' HG3' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -74.21 160.96 30.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.57 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.518 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -45.88 -60.21 2.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.64 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -51.83 -25.49 7.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.641 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.412 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 1.1 mt-30 -92.28 -35.6 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 0.0 111.247 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 t -102.31 -120.15 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.325 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.5 m80 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.762 0.315 . . . . 0.0 111.303 -179.548 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.641 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.492 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -36.64 -30.08 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -70.39 0.1 7.2 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.0 t70 -108.94 145.12 31.04 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-O 120.67 0.271 . . . . 0.0 110.701 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.3 Cg_endo -47.3 122.88 7.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.962 2.441 . . . . 0.0 112.705 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -38.41 135.71 0.89 Allowed Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.576 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.34 -24.11 75.61 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.55 2.167 . . . . 0.0 112.625 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.5 p -58.75 -30.06 67.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.77 38.66 8.59 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.546 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.4 m -90.01 -32.88 16.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.96 -40.1 1.67 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.56 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 12.0 mttt -85.25 166.11 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.767 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -74.58 -177.14 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.341 179.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.492 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -60.97 -58.41 8.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.942 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -63.14 -26.19 68.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.945 0.402 . . . . 0.0 110.791 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 1.5 mt-30 -92.71 15.01 15.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.25 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 t -150.02 -78.73 0.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.391 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.1 m80 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.643 179.838 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.697 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.512 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.52 -30.48 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.96 0.32 6.14 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -106.42 147.15 34.4 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.76 0.314 . . . . 0.0 110.736 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 71.3 Cg_exo -48.6 122.71 8.32 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.657 2.238 . . . . 0.0 112.363 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.1 t -39.48 133.74 1.26 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.576 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 -16.25 54.35 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.541 2.161 . . . . 0.0 112.836 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.5 p -58.06 -29.2 65.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.757 0.313 . . . . 0.0 111.031 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.19 30.81 10.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.55 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 m -90.18 -50.61 5.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 0.0 110.967 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.39 -27.92 2.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -88.91 156.47 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -73.28 162.54 29.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.484 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.512 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.45 -62.28 1.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.3 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -25.12 9.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.401 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -90.84 -28.49 18.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 111.158 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.0 t -111.62 -120.07 0.29 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.207 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.5 m80 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.755 0.312 . . . . 0.0 111.375 -179.526 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 111.249 -0.741 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.499 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.51 -30.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -72.26 0.66 9.32 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.5 t70 -107.16 145.31 30.9 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.681 0.277 . . . . 0.0 110.749 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.0 Cg_endo -46.2 122.86 5.85 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.853 2.369 . . . . 0.0 112.554 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -40.02 135.5 1.35 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.656 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.92 -22.95 74.16 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.59 2.194 . . . . 0.0 112.581 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.7 p -59.1 -31.41 68.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 111.003 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.76 36.74 7.69 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.56 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -90.01 -31.41 17.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.985 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.51 -39.56 1.91 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.375 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.43 154.32 21.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 110.837 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.482 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -71.62 168.66 17.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.431 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -46.27 -61.83 1.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.004 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -56.7 -29.34 62.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.667 -179.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.482 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 7.8 mm100 -98.19 19.72 13.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.586 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.6 t -150.39 -80.54 0.12 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.577 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.7 m80 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.752 179.781 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.0 ttt180 -45.61 -28.94 1.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -86.38 0.39 54.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.603 0.239 . . . . 0.0 111.636 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.66 145.56 30.12 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.538 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.1 Cg_endo -43.54 118.86 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.016 2.477 . . . . 0.0 112.585 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.9 t -38.88 135.32 1.0 Allowed Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.55 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.13 -20.39 67.64 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.574 2.183 . . . . 0.0 112.544 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.2 p -57.64 -29.18 64.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.349 . . . . 0.0 111.022 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.93 32.42 21.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.721 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -90.23 -29.77 17.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.927 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.46 -29.04 5.36 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.301 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -86.12 156.91 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.673 0.273 . . . . 0.0 110.791 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -71.85 -178.51 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.407 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -64.74 -62.76 1.38 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.834 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -55.57 -28.29 54.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.956 0.408 . . . . 0.0 110.811 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.68 7.39 36.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.299 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 t -149.97 -120.03 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.965 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.6 m80 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.811 0.339 . . . . 0.0 110.91 -179.925 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.513 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -36.92 -29.94 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -178.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.99 0.24 9.87 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.7 t70 -106.88 145.21 30.64 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-O 120.712 0.291 . . . . 0.0 110.704 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.1 Cg_endo -46.52 122.26 5.57 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.9 2.4 . . . . 0.0 112.442 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -39.08 134.64 1.08 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.538 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.92 -19.47 64.0 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.612 2.208 . . . . 0.0 112.562 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -55.53 -29.87 59.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.018 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.02 33.28 9.04 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.556 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -89.8 -59.26 2.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.33 -28.61 0.78 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.607 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.05 155.55 17.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -68.07 166.46 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.522 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.513 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -45.86 -68.83 0.16 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.145 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -24.5 16.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -96.44 13.69 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.303 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 t -150.22 -74.85 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.836 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.7 m80 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.714 0.292 . . . . 0.0 111.316 -179.514 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 1.7 ttt85 -46.93 -28.05 1.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -86.9 0.87 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.717 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -99.42 145.54 30.24 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.574 0.226 . . . . 0.0 110.648 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.2 Cg_endo -42.62 119.65 1.5 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.013 2.475 . . . . 0.0 112.451 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -39.2 135.24 1.09 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.57 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.94 -22.53 74.48 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.558 2.172 . . . . 0.0 112.591 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -56.61 -30.58 63.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.36 36.12 10.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.576 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -90.02 -48.42 7.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.911 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.31 -28.23 1.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.406 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -92.83 152.25 19.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -72.8 163.13 28.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.668 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -45.97 -60.93 1.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.661 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.402 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 2.8 pttt -49.43 -26.54 3.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.936 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.433 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 10.7 mm-40 -92.91 -43.29 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.546 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.2 t -91.88 -120.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.723 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.1 m80 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.713 0.292 . . . . 0.0 111.505 -179.338 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.527 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -35.71 -30.52 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -70.49 0.14 7.3 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.4 t70 -104.71 145.34 30.51 Favored Pre-proline 0 C--O 1.232 0.16 0 CA-C-O 120.629 0.252 . . . . 0.0 110.632 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.2 Cg_endo -46.94 121.54 5.18 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.903 2.402 . . . . 0.0 112.35 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -37.75 135.19 0.79 Allowed Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.603 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.23 -23.49 59.61 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.519 2.146 . . . . 0.0 112.658 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.5 p -57.01 -29.72 63.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.93 37.46 6.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.523 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.8 p -90.14 -34.62 15.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.03 -26.14 5.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.459 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 1.2 mptt -96.53 160.73 14.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -73.32 166.12 23.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.521 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.527 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -49.09 -68.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.352 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.24 -24.63 2.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.632 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 6.9 mm100 -89.76 -27.34 20.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.63 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' LYS . 12.0 t -110.04 -80.98 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.0 m80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.491 -179.34 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.568 0 N-CA-C 111.279 -0.729 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.499 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 1.1 ttt85 -46.4 -28.6 1.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -87.0 1.1 53.94 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -97.77 145.32 29.54 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.701 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -42.58 118.83 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.067 2.511 . . . . 0.0 112.487 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -40.29 135.19 1.45 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.66 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.4 -21.5 66.5 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.533 2.156 . . . . 0.0 112.549 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.6 p -56.37 -30.36 62.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.337 . . . . 0.0 111.009 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.12 33.97 10.24 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.517 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -90.07 -35.55 15.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.814 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.38 -28.33 4.29 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.451 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -89.11 163.42 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.463 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -85.74 160.15 19.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 179.717 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -43.65 -62.16 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.751 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -47.97 -27.37 2.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.003 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.463 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 2.5 tt0 -94.6 -36.76 11.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.65 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 t -99.85 -120.13 0.15 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.538 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.0 m80 . . . . . 0 C--O 1.231 0.108 0 O-C-N 122.274 -0.266 . . . . 0.0 111.654 -179.296 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.447 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.479 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 14.2 ttp180 -47.83 -28.04 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -84.22 0.78 47.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.616 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -101.5 145.19 30.02 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.64 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -42.42 120.0 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.092 2.528 . . . . 0.0 112.39 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -40.21 135.67 1.39 Allowed Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.478 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.66 -20.26 49.77 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.546 2.164 . . . . 0.0 112.604 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.0 p -60.04 -31.33 69.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.87 0.367 . . . . 0.0 110.893 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.57 35.53 13.71 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.57 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -90.18 -44.92 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.909 0.385 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.74 -29.14 2.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.434 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.73 134.17 34.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -55.8 166.18 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.759 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.479 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -45.9 -61.06 1.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.584 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HG2' ' HG3' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -52.41 -35.41 51.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.534 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.443 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 9.1 mm100 -90.61 13.73 15.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.573 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 t -150.36 -120.6 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.545 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.3 m80 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.69 0.281 . . . . 0.0 111.44 -179.612 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.856 0.36 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 3' ' ' GLY . 14.8 p -123.45 158.87 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.195 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.503 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -81.24 84.65 1.43 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.436 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.512 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -37.12 -29.54 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -70.49 0.15 7.26 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 3' ' ' GLY . 6.0 t70 -108.43 144.88 30.4 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.59 0.233 . . . . 0.0 110.578 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.3 Cg_endo -47.38 123.8 8.4 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.692 2.261 . . . . 0.0 112.314 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 t -38.66 134.67 0.98 Allowed Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.719 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.1 -21.41 65.53 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.576 2.184 . . . . 0.0 112.556 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -57.64 -30.25 65.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.826 0.346 . . . . 0.0 111.031 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.34 34.69 11.76 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.522 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.7 p -90.15 -41.21 11.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.874 0.368 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.14 -28.72 2.89 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.459 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.9 153.16 20.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.707 0.289 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -74.99 163.53 27.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.56 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.512 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.0 -59.85 2.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.947 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.402 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -50.34 -24.67 3.14 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.049 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.476 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -98.11 -28.52 13.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.683 0.278 . . . . 0.0 111.718 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.0 t -107.19 -120.52 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.866 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -60.8 -38.52 85.65 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.703 0.287 . . . . 0.0 111.749 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.405 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -47.77 -27.52 4.75 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.837 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.858 179.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.781 0.324 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.446 ' CG1' ' CD2' ' A' ' 16' ' ' TYR . 12.9 p -114.74 149.27 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.297 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.19 81.16 0.58 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.283 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.498 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -34.72 -33.08 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.28 -7.82 4.86 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -99.06 144.79 28.86 Favored Pre-proline 0 C--N 1.332 -0.157 0 CA-C-O 120.634 0.254 . . . . 0.0 110.657 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 6.4 Cg_endo -48.54 120.2 4.94 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.736 2.29 . . . . 0.0 112.306 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 t -34.57 133.72 0.41 Allowed Pre-proline 0 N--CA 1.467 0.385 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.742 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.73 -17.64 55.95 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.642 2.228 . . . . 0.0 112.72 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 p -57.18 -28.13 62.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.0 111.014 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.13 30.69 16.31 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.58 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 94.8 p -90.33 -49.16 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.828 0.347 . . . . 0.0 110.925 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.85 -27.13 2.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.422 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -88.27 150.56 23.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.807 0.336 . . . . 0.0 110.948 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -67.5 161.61 25.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.558 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.498 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -47.53 -66.29 0.43 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.302 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.83 -25.78 4.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.31 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -89.81 -19.67 24.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.358 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 t -119.05 -119.73 0.31 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.746 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -67.31 -22.54 65.62 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -48.3 -27.22 5.39 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.835 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.871 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.77 0.319 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 3' ' ' GLY . 14.1 p -120.03 158.53 21.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.504 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -76.76 81.99 1.1 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.543 -0.836 . . . . 0.0 111.412 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.509 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -36.79 -29.77 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -69.49 -0.96 7.37 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.3 t70 -106.16 145.18 30.43 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-O 120.608 0.242 . . . . 0.0 110.633 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.3 Cg_endo -47.2 122.58 6.61 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.862 2.375 . . . . 0.0 112.284 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.6 t -38.77 134.14 1.02 Allowed Pre-proline 0 N--CA 1.463 0.212 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.653 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.14 -19.68 66.36 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.599 2.199 . . . . 0.0 112.752 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.0 p -55.68 -29.23 59.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.79 0.329 . . . . 0.0 111.057 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.52 32.0 9.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.611 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.8 p -90.07 -49.38 6.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.859 0.362 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.5 -27.91 2.47 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.466 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -89.97 154.09 20.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -70.56 161.93 29.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.592 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.509 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -46.49 -63.56 0.98 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.503 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.73 -25.68 4.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.582 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -89.99 -34.01 16.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.376 . . . . 0.0 111.156 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.9 t -104.54 -119.96 0.21 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.29 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -53.18 -46.07 68.81 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.745 0.307 . . . . 0.0 111.291 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.35 -44.79 65.92 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.54 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.175 -0.917 . . . . 0.0 110.884 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.802 0.334 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.478 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.2 p -102.96 147.47 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.134 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.49 95.07 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.481 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.521 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 34.4 ttt180 -47.12 -27.95 1.6 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -85.75 0.48 52.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -100.55 145.29 30.06 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.582 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.2 Cg_endo -42.92 119.64 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.041 2.494 . . . . 0.0 112.441 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -38.04 135.11 0.85 Allowed Pre-proline 0 N--CA 1.465 0.291 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.668 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.7 -21.92 71.26 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.559 2.173 . . . . 0.0 112.648 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 29.7 p -57.45 -38.08 73.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.769 0.319 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.83 33.63 6.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.64 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -90.25 -29.72 17.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.804 0.335 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.77 -28.05 6.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.41 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 151.26 22.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.332 . . . . 0.0 110.77 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -71.15 166.5 21.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.538 179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.521 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -48.7 -64.59 0.76 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.448 -179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -25.36 8.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.385 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -89.76 -26.83 20.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.272 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 15' ' ' LYS . 8.7 t -113.65 -120.05 0.3 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.263 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -59.13 -43.51 91.97 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.731 0.301 . . . . 0.0 111.191 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -54.02 -23.43 23.87 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.684 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.959 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.855 0.359 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.479 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.9 p -114.86 146.79 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.18 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.79 96.56 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.327 -0.94 . . . . 0.0 111.275 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.508 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 4.1 ttt85 -47.41 -27.9 1.88 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -87.08 0.7 54.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.687 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.07 146.47 31.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.703 0.287 . . . . 0.0 110.591 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 98.7 Cg_exo -42.61 119.08 1.31 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.749 2.299 . . . . 0.0 112.607 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 t -41.08 134.49 1.79 Allowed Pre-proline 0 CA--C 1.531 0.221 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.546 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.01 -18.73 64.82 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.597 2.198 . . . . 0.0 112.799 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.3 p -55.94 -26.23 46.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.795 0.331 . . . . 0.0 111.17 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.07 28.71 22.38 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.675 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.4 p -90.33 -33.36 16.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.781 0.324 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.19 -28.41 6.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.38 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -83.81 152.68 24.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.332 . . . . 0.0 110.769 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -72.41 163.49 27.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.672 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -47.86 -61.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.159 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -54.37 -30.94 53.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.018 0.437 . . . . 0.0 110.891 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.47 8.3 34.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.419 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.08 -120.34 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.107 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -59.17 -40.59 86.11 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.73 0.3 . . . . 0.0 110.958 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.09 -40.74 93.99 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.378 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.328 -0.844 . . . . 0.0 110.959 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.726 0.298 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.475 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.8 p -123.92 147.21 28.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.187 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.24 94.74 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.244 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.502 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 12.6 ttp-105 -47.21 -27.73 1.6 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -85.06 0.65 50.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.67 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.1 146.46 31.75 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.698 0.285 . . . . 0.0 110.728 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 96.3 Cg_exo -43.05 118.81 1.38 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.739 2.293 . . . . 0.0 112.655 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 t -40.26 134.44 1.49 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.516 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.22 -16.72 52.72 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.608 2.206 . . . . 0.0 112.777 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.6 p -56.76 -26.19 56.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.752 0.31 . . . . 0.0 111.159 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.83 28.52 26.05 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.592 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.0 m -90.27 -40.51 12.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.851 0.358 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.05 -27.48 4.05 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.287 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -85.19 149.02 25.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.805 0.336 . . . . 0.0 110.771 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -68.51 165.95 17.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.768 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.502 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -49.79 -63.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.234 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 0.9 OUTLIER -52.17 -30.73 28.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.907 0.384 . . . . 0.0 110.985 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.03 8.69 31.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.571 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -150.2 -120.28 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.489 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -66.37 -27.08 67.6 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 122.328 -0.233 . . . . 0.0 111.575 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -50.28 -26.22 9.16 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.787 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.886 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.3 mmtm . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.85 0.357 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 12.7 p -93.54 144.35 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.3 97.22 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.363 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.475 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 38.1 ttt180 -48.24 -27.89 2.73 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -86.11 0.35 53.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.7 0.286 . . . . 0.0 111.615 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -100.75 145.61 30.65 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.594 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.2 Cg_endo -42.57 119.46 1.42 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.082 2.522 . . . . 0.0 112.416 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 t -38.67 135.25 0.96 Allowed Pre-proline 0 N--CA 1.465 0.315 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.528 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -56.97 -20.91 38.78 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.569 2.179 . . . . 0.0 112.632 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -58.94 -28.35 66.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.772 0.32 . . . . 0.0 110.901 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.05 34.08 24.88 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.636 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -90.14 -37.96 13.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 0.0 110.919 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.64 -27.85 3.47 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.478 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -89.33 140.29 29.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.717 0.294 . . . . 0.0 110.917 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.26 165.52 3.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.723 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.475 ' HB3' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.37 -65.71 0.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.263 -179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -24.58 9.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.252 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -89.83 -18.34 26.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.263 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 t -121.96 -120.1 0.29 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.542 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -66.73 -30.32 70.52 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 122.25 -0.281 . . . . 0.0 111.713 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.44 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -49.37 -26.45 6.94 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.793 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.912 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.765 0.316 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.492 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 9.7 p -117.11 150.26 19.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.15 94.82 0.1 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.318 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.474 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -46.97 -28.88 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.029 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -84.73 0.83 49.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.649 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.18 145.25 30.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.635 0.255 . . . . 0.0 110.694 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -43.47 119.66 1.86 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.021 2.481 . . . . 0.0 112.444 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -38.67 134.78 0.98 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.619 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.22 -21.14 72.08 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.609 2.206 . . . . 0.0 112.555 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -56.61 -34.52 67.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.993 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.63 35.09 7.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.572 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -90.03 -51.39 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.0 110.914 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.75 -33.99 1.26 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.38 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -88.06 150.02 23.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -62.41 171.11 2.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.479 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.492 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -47.82 -70.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -24.09 19.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 111.014 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -93.39 13.27 22.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.307 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.2 t -150.14 -75.66 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.809 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -114.18 -35.21 5.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 111.322 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.8 -25.12 14.84 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.666 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.798 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.2 mttm . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.855 0.36 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.494 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 12.8 p -111.89 144.18 20.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.172 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.15 96.37 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.391 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.523 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.7 ttt180 -47.0 -28.37 1.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -87.22 0.68 54.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -96.89 145.37 29.46 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.653 -0.248 . . . . 0.0 110.651 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -42.19 118.33 0.98 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.096 2.531 . . . . 0.0 112.503 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.418 ' H ' ' HA ' ' A' ' 15' ' ' LYS . 1.8 t -40.21 135.53 1.4 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.544 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -68.79 -21.82 37.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.52 2.147 . . . . 0.0 112.695 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.5 p -55.51 -29.09 58.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.763 0.316 . . . . 0.0 111.08 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.72 33.31 8.5 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.526 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -90.05 -32.15 16.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.361 . . . . 0.0 110.953 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.72 -31.75 4.47 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.487 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 17.1 mttt -87.85 166.3 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.328 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -86.04 161.47 18.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.672 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.523 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -43.35 -63.14 0.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.784 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.46 -25.63 2.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.701 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -89.96 -43.42 10.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.958 0.408 . . . . 0.0 111.391 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.3 t -98.86 -112.56 0.16 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.723 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.7 m80 -55.11 -53.45 55.72 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.682 0.277 . . . . 0.0 111.566 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.02 -28.09 3.84 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.941 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.3 mptt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.807 0.337 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.506 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.3 p -110.9 143.77 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.222 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.41 96.74 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.289 -0.957 . . . . 0.0 111.322 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.476 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.2 ttt180 -46.13 -28.72 1.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -84.95 0.39 51.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -101.69 145.74 31.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.678 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.8 Cg_endo -44.15 119.94 2.28 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.99 2.46 . . . . 0.0 112.581 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -37.67 135.62 0.76 Allowed Pre-proline 0 N--CA 1.464 0.244 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.694 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.35 -25.9 80.0 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.574 2.182 . . . . 0.0 112.449 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.4 p -57.84 -39.41 77.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.947 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.21 41.67 5.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.631 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.11 -42.29 11.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.38 -36.68 1.35 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.383 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -90.55 164.54 14.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.319 . . . . 0.0 110.739 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -72.74 -178.07 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.536 179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.506 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.4 OUTLIER -57.78 -68.05 0.28 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.025 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -18.88 12.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.444 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 2.3 mm100 -89.44 -29.6 18.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.359 . . . . 0.0 111.238 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.6 t -107.04 -85.78 0.5 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.007 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -87.7 -51.47 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.72 0.295 . . . . 0.0 111.311 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 16' ' ' TYR . . . -47.2 -30.91 5.86 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.73 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.005 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.7 mtpt . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.825 0.345 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.455 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.5 p -107.58 149.94 10.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.256 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -71.53 80.81 0.52 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.269 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.518 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -34.99 -31.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -66.26 -3.54 6.02 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.9 t70 -102.14 144.81 29.33 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-O 120.655 0.264 . . . . 0.0 110.513 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -47.58 121.38 5.53 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.83 2.353 . . . . 0.0 112.302 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 t -36.52 134.31 0.61 Allowed Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.696 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.51 -20.22 69.24 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.561 2.174 . . . . 0.0 112.744 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.4 p -57.17 -33.86 67.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.834 0.35 . . . . 0.0 110.957 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.31 33.4 6.88 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.577 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 t -90.2 -44.03 10.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.802 0.334 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.04 -28.43 2.93 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.472 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -89.65 156.23 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.822 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HB2' ' HG3' ' A' ' 18' ' ' GLN . 0.8 OUTLIER -74.21 160.96 30.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.57 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.518 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -45.88 -60.21 2.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.64 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.2 ptmt -51.83 -25.49 7.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.641 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.412 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 1.1 mt-30 -92.28 -35.6 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 0.0 111.247 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 t -102.31 -120.15 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.325 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -56.72 -47.77 79.22 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.762 0.315 . . . . 0.0 111.303 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -52.54 -24.47 17.7 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.743 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.868 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.85 0.357 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 3' ' ' GLY . 14.0 p -119.01 158.92 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.501 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -82.7 85.97 1.48 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.398 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.492 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -36.64 -30.08 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -70.39 0.1 7.2 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.0 t70 -108.94 145.12 31.04 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-O 120.67 0.271 . . . . 0.0 110.701 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.3 Cg_endo -47.3 122.88 7.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.962 2.441 . . . . 0.0 112.705 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -38.41 135.71 0.89 Allowed Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.576 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.34 -24.11 75.61 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.55 2.167 . . . . 0.0 112.625 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.5 p -58.75 -30.06 67.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.77 38.66 8.59 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.546 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.4 m -90.01 -32.88 16.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.762 0.315 . . . . 0.0 110.909 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.96 -40.1 1.67 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.56 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 12.0 mttt -85.25 166.11 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.767 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -74.58 -177.14 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.341 179.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.492 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -60.97 -58.41 8.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.942 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -63.14 -26.19 68.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.945 0.402 . . . . 0.0 110.791 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 1.5 mt-30 -92.71 15.01 15.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.25 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 t -150.02 -78.73 0.13 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.391 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.49 ' O ' ' N ' ' A' ' 22' ' ' ARG . 28.1 m80 -105.64 -86.14 0.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.643 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.456 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . 52.22 -84.06 0.01 OUTLIER Glycine 0 C--N 1.333 0.372 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.927 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 20' ' ' HIS . 4.2 mtt180 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.79 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.762 0.315 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.502 HG22 ' N ' ' A' ' 3' ' ' GLY . 14.7 p -102.81 158.28 4.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.502 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -78.81 84.36 1.22 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.337 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.512 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.52 -30.48 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.96 0.32 6.14 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -106.42 147.15 34.4 Favored Pre-proline 0 C--N 1.332 -0.174 0 CA-C-O 120.76 0.314 . . . . 0.0 110.736 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 71.3 Cg_exo -48.6 122.71 8.32 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.657 2.238 . . . . 0.0 112.363 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.1 t -39.48 133.74 1.26 Allowed Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.576 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 -16.25 54.35 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.541 2.161 . . . . 0.0 112.836 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.5 p -58.06 -29.2 65.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.757 0.313 . . . . 0.0 111.031 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.19 30.81 10.41 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.55 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 m -90.18 -50.61 5.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 0.0 110.967 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.39 -27.92 2.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -88.91 156.47 18.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -73.28 162.54 29.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.484 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.512 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.45 -62.28 1.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.3 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -25.12 9.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.401 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -90.84 -28.49 18.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 111.158 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.0 t -111.62 -120.07 0.29 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.207 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -58.09 -45.0 87.91 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.755 0.312 . . . . 0.0 111.375 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.437 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -51.89 -25.04 15.31 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.765 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.939 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.6 mttt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.726 0.298 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 3' ' ' GLY . 13.9 p -118.14 158.76 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.251 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.498 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -80.15 84.1 1.36 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.249 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.499 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.51 -30.36 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -72.26 0.66 9.32 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.5 t70 -107.16 145.31 30.9 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.681 0.277 . . . . 0.0 110.749 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.0 Cg_endo -46.2 122.86 5.85 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.853 2.369 . . . . 0.0 112.554 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -40.02 135.5 1.35 Allowed Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.656 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.92 -22.95 74.16 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.59 2.194 . . . . 0.0 112.581 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.7 p -59.1 -31.41 68.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 111.003 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.76 36.74 7.69 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.56 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -90.01 -31.41 17.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.985 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.51 -39.56 1.91 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.375 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.43 154.32 21.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 110.837 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.482 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -71.62 168.66 17.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.431 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -46.27 -61.83 1.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 112.004 -179.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -56.7 -29.34 62.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.667 -179.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.482 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 7.8 mm100 -98.19 19.72 13.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.586 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.6 t -150.39 -80.54 0.12 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.577 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.484 ' O ' ' N ' ' A' ' 22' ' ' ARG . 24.7 m80 -105.72 -88.34 0.44 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.752 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.467 ' HA2' ' CE2' ' A' ' 16' ' ' TYR . . . 52.81 -83.77 0.01 OUTLIER Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.825 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 20' ' ' HIS . 6.3 mtt-85 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.912 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.3 mttt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.795 0.331 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.494 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 11.8 p -88.3 145.79 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.19 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.51 96.71 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.073 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.0 ttt180 -45.61 -28.94 1.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -86.38 0.39 54.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.603 0.239 . . . . 0.0 111.636 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.66 145.56 30.12 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.538 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.1 Cg_endo -43.54 118.86 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.016 2.477 . . . . 0.0 112.585 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.9 t -38.88 135.32 1.0 Allowed Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.55 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.13 -20.39 67.64 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.574 2.183 . . . . 0.0 112.544 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.2 p -57.64 -29.18 64.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.349 . . . . 0.0 111.022 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.93 32.42 21.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.721 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 m -90.23 -29.77 17.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.927 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.46 -29.04 5.36 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.301 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -86.12 156.91 20.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.673 0.273 . . . . 0.0 110.791 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -71.85 -178.51 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.407 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -64.74 -62.76 1.38 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.834 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -55.57 -28.29 54.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.956 0.408 . . . . 0.0 110.811 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.68 7.39 36.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.299 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 t -149.97 -120.03 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.965 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -59.76 -40.2 87.36 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.811 0.339 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.17 -40.19 95.43 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.534 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.891 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.905 0.383 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 3' ' ' GLY . 14.7 p -109.7 158.63 9.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.214 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.501 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -81.29 84.46 1.44 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.256 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.513 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -36.92 -29.94 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -178.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.99 0.24 9.87 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.7 t70 -106.88 145.21 30.64 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-O 120.712 0.291 . . . . 0.0 110.704 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 4.1 Cg_endo -46.52 122.26 5.57 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.9 2.4 . . . . 0.0 112.442 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -39.08 134.64 1.08 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.538 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.92 -19.47 64.0 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.612 2.208 . . . . 0.0 112.562 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.2 p -55.53 -29.87 59.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.018 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.02 33.28 9.04 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.556 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -89.8 -59.26 2.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.831 0.348 . . . . 0.0 110.952 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.33 -28.61 0.78 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.607 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.05 155.55 17.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -68.07 166.46 15.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.522 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.513 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -45.86 -68.83 0.16 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.145 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -24.5 16.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -96.44 13.69 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.303 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 t -150.22 -74.85 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.836 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -117.84 -36.1 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.714 0.292 . . . . 0.0 111.316 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.454 ' CA ' ' CD2' ' A' ' 16' ' ' TYR . . . -47.68 -27.93 4.85 Favored Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.844 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.817 0.341 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.487 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 11.6 p -101.04 149.41 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.27 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.08 93.82 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.263 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 1.7 ttt85 -46.93 -28.05 1.48 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -86.9 0.87 54.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.717 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -99.42 145.54 30.24 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.574 0.226 . . . . 0.0 110.648 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.2 Cg_endo -42.62 119.65 1.5 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.013 2.475 . . . . 0.0 112.451 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.6 t -39.2 135.24 1.09 Allowed Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.57 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.94 -22.53 74.48 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.558 2.172 . . . . 0.0 112.591 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -56.61 -30.58 63.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.787 0.327 . . . . 0.0 110.94 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.36 36.12 10.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.576 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -90.02 -48.42 7.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.911 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 144.31 -28.23 1.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.406 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -92.83 152.25 19.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -72.8 163.13 28.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.668 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -45.97 -60.93 1.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.661 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.402 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 2.8 pttt -49.43 -26.54 3.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.936 -179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.433 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 10.7 mm-40 -92.91 -43.29 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.546 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.2 t -91.88 -120.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.723 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -59.63 -45.6 91.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.713 0.292 . . . . 0.0 111.505 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.435 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -50.98 -25.45 9.82 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.844 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.862 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.9 mtmm . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.791 0.329 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.4 p -117.66 152.56 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.204 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -72.78 80.78 0.66 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.253 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.527 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -35.71 -30.52 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -70.49 0.14 7.3 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.4 t70 -104.71 145.34 30.51 Favored Pre-proline 0 C--O 1.232 0.16 0 CA-C-O 120.629 0.252 . . . . 0.0 110.632 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 5.2 Cg_endo -46.94 121.54 5.18 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.903 2.402 . . . . 0.0 112.35 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -37.75 135.19 0.79 Allowed Pre-proline 0 N--CA 1.465 0.297 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.603 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.23 -23.49 59.61 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.519 2.146 . . . . 0.0 112.658 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.5 p -57.01 -29.72 63.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.93 37.46 6.8 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.523 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.8 p -90.14 -34.62 15.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.03 -26.14 5.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.459 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 18' ' ' GLN . 1.2 mptt -96.53 160.73 14.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.783 0.325 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -73.32 166.12 23.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.521 179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.527 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -49.09 -68.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.352 -179.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.426 ' HA ' ' N ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -50.24 -24.63 2.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.632 -179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 6.9 mm100 -89.76 -27.34 20.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.63 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.409 ' N ' ' O ' ' A' ' 15' ' ' LYS . 12.0 t -110.04 -80.98 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -100.28 -47.39 4.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.491 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.402 ' HA3' ' CD2' ' A' ' 16' ' ' TYR . . . -47.05 -28.05 3.87 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.758 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.426 ' N ' ' HA ' ' A' ' 17' ' ' LYS . 6.9 mmt180 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.801 0.334 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.502 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.9 p -84.28 144.99 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.67 96.45 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.279 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.499 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 1.1 ttt85 -46.4 -28.6 1.4 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -87.0 1.1 53.94 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -97.77 145.32 29.54 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.701 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -42.58 118.83 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.067 2.511 . . . . 0.0 112.487 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -40.29 135.19 1.45 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.66 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.4 -21.5 66.5 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.533 2.156 . . . . 0.0 112.549 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.6 p -56.37 -30.36 62.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.337 . . . . 0.0 111.009 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.12 33.97 10.24 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.517 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 m -90.07 -35.55 15.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.814 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.38 -28.33 4.29 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.451 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -89.11 163.42 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.463 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -85.74 160.15 19.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 179.717 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.502 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -43.65 -62.16 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.751 -179.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -47.97 -27.37 2.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.003 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.463 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 2.5 tt0 -94.6 -36.76 11.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.65 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 t -99.85 -120.13 0.15 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.538 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -57.76 -47.3 82.88 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 122.274 -0.266 . . . . 0.0 111.654 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.419 ' HA3' ' CG ' ' A' ' 16' ' ' TYR . . . -47.1 -45.26 20.25 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.92 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.965 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.916 0.388 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.498 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 12.1 p -102.87 138.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.128 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.29 98.22 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.496 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.479 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 14.2 ttp180 -47.83 -28.04 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -84.22 0.78 47.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.616 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -101.5 145.19 30.02 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.64 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -42.42 120.0 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.092 2.528 . . . . 0.0 112.39 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.0 t -40.21 135.67 1.39 Allowed Pre-proline 0 N--CA 1.464 0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.478 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.66 -20.26 49.77 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.546 2.164 . . . . 0.0 112.604 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.0 p -60.04 -31.33 69.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.87 0.367 . . . . 0.0 110.893 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.57 35.53 13.71 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.57 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 m -90.18 -44.92 9.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.909 0.385 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.74 -29.14 2.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.434 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.73 134.17 34.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -55.8 166.18 0.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.759 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.498 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -45.9 -61.06 1.89 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.584 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HG2' ' HG3' ' A' ' 15' ' ' LYS . 0.6 OUTLIER -52.41 -35.41 51.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.534 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.443 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 9.1 mm100 -90.61 13.73 15.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.573 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 t -150.36 -120.6 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.545 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -67.4 -28.27 67.78 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.69 0.281 . . . . 0.0 111.44 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.08 -24.44 20.85 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.76 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_